,docId,isValid,passage,passage_id,e1,e2
0,IEPA.d0,True,Oxytocin stimulates IP3 production in dose-dependent fashion as well,IEPA.d0.s0,Oxytocin,IP3
1,IEPA.d1,True,"Phosphoinositide hydrolysis, resulting in inositol trisphosphate (IP3) and diacylglycerol (DG) formation, has been implicated in oxytocin-stimulated pulsatile secretion of prostaglandin F2 alpha (PGF2 alpha) from uterine endometrium of sheep and other mammals",IEPA.d1.s1,inositol trisphosphate,oxytocin
2,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,inositol trisphosphate,oxytocin
3,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,inositol phosphate,oxytocin
4,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,oxytocin,IP3
5,IEPA.d2,True,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,oxytocin,IP
6,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,inositol trisphosphate,inositol phosphate
7,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,inositol trisphosphate,IP3
8,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,inositol trisphosphate,IP
9,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,inositol phosphate,IP3
10,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,inositol phosphate,IP
11,IEPA.d2,False,"SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16",IEPA.d2.s2,IP3,IP
12,IEPA.d2,True,"These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to oxytocin and, therefore, reduce oxytocin-induced synthesis of IP3 and PGF2 alpha",IEPA.d2.s3,oxytocin,IP3
13,IEPA.d2,False,"These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to oxytocin and, therefore, reduce oxytocin-induced synthesis of IP3 and PGF2 alpha",IEPA.d2.s3,oxytocin,oxytocin
14,IEPA.d2,False,"These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to oxytocin and, therefore, reduce oxytocin-induced synthesis of IP3 and PGF2 alpha",IEPA.d2.s3,oxytocin,IP3
15,IEPA.d3,False,"Inositol 1,4,5-trisphosphate and oxytocin binding in human myometrium",IEPA.d3.s4,"Inositol 1,4,5-trisphosphate",oxytocin
16,IEPA.d4,False,The effects of prostaglandin F2 alpha (PGF2 alpha) on intracellular Ca2+ concentration ([Ca2+]i) and inositol phosphate (IP) generation in human myometrial cells were evaluated and compared to the effects of oxytocin,IEPA.d4.s5,inositol phosphate,oxytocin
17,IEPA.d4,True,"In contrast, the potencies of oxytocin to raise IP and [Ca2+]i were similar and independent of extracellular Ca2+, and could be suppressed by pertussis toxin and phorbol ester, but not by verapamil",IEPA.d4.s6,oxytocin,IP
18,IEPA.d4,True,"The action of PGF2 alpha depends on extracellular Ca2+, whereas oxytocin activates the G-protein-dependent phospholipase-C-IP3-Ca2+ signal-transducing pathway, complemented by the influx of extracellular Ca2+",IEPA.d4.s7,oxytocin,IP3
19,IEPA.d8,False,"The objectives of this study were to evaluate and compare the actions of endothelin-1 (ET-1), oxytocin, prostaglandin F2 alpha (PGF2 alpha) and inositol 1,4,5-trisphosphate (IP3) on 45Ca2+ mobilization in permeabilized rat myometrial cells and to examine the activation of the inositol lipid cycle in intact myocytes",IEPA.d8.s14,oxytocin,"inositol 1,4,5-trisphosphate"
20,IEPA.d8,False,"All four agonists caused a biphasic release of 45Ca2+ from non-mitochondrial pool(s), with the rank order of potency: oxytocin > PGF2 alpha > ET-1 > IP3",IEPA.d8.s15,oxytocin,IP3
21,IEPA.d8,True,"Endothelin-1 and oxytocin stimulated inositol phosphate accumulation at concentrations similar to those that promoted 45Ca2+ efflux, whereas about 100 times higher concentrations of PGF2 alpha were needed to activate this signaling pathway in intact cells",IEPA.d8.s16,oxytocin,inositol phosphate
22,IEPA.d8,True,"It is concluded that the primary action of PGF2 alpha in myometrial cells is to enhance Ca2+ influx, whereas oxytocin and ET-1 receptors are coupled to phospholipase C, generating IP3 and raising the intracellular concentration of free Ca2+ from intracellular as well as extracellular sources",IEPA.d8.s17,oxytocin,IP3
23,IEPA.d9,False,"Oxytocin induced a biphasic increase in the intracellular Ca2+ concentration of porcine myometrial cells: participation of a pertussis toxin-insensitive G-protein, inositol 1,4,5-trisphosphate-sensitive Ca2+ pool, and Ca2+ channels",IEPA.d9.s18,Oxytocin,"inositol 1,4,5-trisphosphate"
24,IEPA.d9,True,"Administration of OT (1 microM) for 15 sec increased inositol 1,4,5-trisphosphate (IP3) formation by 61%",IEPA.d9.s19,OT,"inositol 1,4,5-trisphosphate"
25,IEPA.d9,True,"Pretreatment with pertussis toxin (PTX, 1 microgram/ml) for 2 hr failed to alter the OT-induced increase in [Ca2+]i and IP3 formation",IEPA.d9.s20,OT,IP3
26,IEPA.d9,True,U-73122 (3 microM) also abolished the OT-induced IP3 formation,IEPA.d9.s21,OT,IP3
27,IEPA.d10,True,Amyloid beta protein disruption of cholinergic and growth factor phospholipase C signals could underlie cognitive and neurodegerative aspects of Alzheimer's disease,IEPA.d10.s22,Amyloid,phospholipase C
28,IEPA.d11,True,"Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells",IEPA.d11.s23,Amyloid,phospholipases
29,IEPA.d11,False,"[3H]Inositol prelabeled LA-N-2 cells were exposed to varying concentrations of A beta P, from 20 to 125 micrograms/ml, and phospholipase C activation was measured",IEPA.d11.s24,A beta P,phospholipase C
30,IEPA.d11,True,"The effects of adrenergic, metabotropic amino acid and bombesin antagonists on the A beta P mediated stimulation of phospholipase C activity was investigated",IEPA.d11.s25,A beta P,phospholipase C
31,IEPA.d11,True,"Propranolol, a beta adrenergic antagonist, 7-chloro-kynurenic acid, a metabotropic amino acid antagonist, and [Tyr4-D-Phe12]bombesin, a bombesin antagonist, blunted the A beta P stimulation of phospholipase C activity in [3H]inositol prelabeled LA-N-2 cells",IEPA.d11.s26,A beta P,phospholipase C
32,IEPA.d11,True,This suggests that amyloid beta protein activation of phospholipase C may be receptor mediated,IEPA.d11.s27,amyloid,phospholipase C
33,IEPA.d11,True,The phospholipase C inhibitor U 71322 prevented the activation of phospholipase C by A beta P,IEPA.d11.s28,phospholipase C,A beta P
34,IEPA.d11,False,The phospholipase C inhibitor U 71322 prevented the activation of phospholipase C by A beta P,IEPA.d11.s28,phospholipase C,phospholipase C
35,IEPA.d11,False,The phospholipase C inhibitor U 71322 prevented the activation of phospholipase C by A beta P,IEPA.d11.s28,phospholipase C,A beta P
36,IEPA.d12,True,These results suggest that APP-S secretion and A beta production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway,IEPA.d12.s29,APP-S,phospholipase C
37,IEPA.d12,True,These results suggest that APP-S secretion and A beta production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway,IEPA.d12.s29,A beta,phospholipase C
38,IEPA.d12,False,These results suggest that APP-S secretion and A beta production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway,IEPA.d12.s29,APP-S,A beta
39,IEPA.d13,False,"Current interest in reducing heart disease risks by diet involves attention to total fat; saturated, monounsaturated, polyunsaturated and trans fatty acids, as well as dietary cholesterol, soluble fiber, salt, alcohol, antioxidants, dietary alterations causing homocysteinemia and other dietary constituents, such as flavonoid compounds in some soy products",IEPA.d13.s30,cholesterol,flavonoid
40,IEPA.d14,False,This indicates that the calcium response to OT application was principally associated with activation of the IP3-sensitive calcium stores,IEPA.d14.s31,OT,IP3
41,IEPA.d15,True,The beta amyloid protein fragments had diverse effects on phosphoinositide-specific phospholipase C (PI-PLC) as assayed in rat cortical membranes,IEPA.d15.s32,amyloid,phospholipase C
42,IEPA.d16,False,"They are needed for the catabolism of cholesterol, bile acids, and steroid hormones; they hydrolyze a number of flavonoid glycosides to anticarcinogens; and they detoxify certain carcinogens",IEPA.d16.s33,cholesterol,flavonoid
43,IEPA.d17,True,"The aim of this study was to investigate the effects of hCG, hCG plus oxytocin and oxytocin on [3H] inositol phosphate (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts",IEPA.d17.s34,oxytocin,inositol phosphate
44,IEPA.d17,True,"The aim of this study was to investigate the effects of hCG, hCG plus oxytocin and oxytocin on [3H] inositol phosphate (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts",IEPA.d17.s34,oxytocin,inositol phosphate
45,IEPA.d17,False,"The aim of this study was to investigate the effects of hCG, hCG plus oxytocin and oxytocin on [3H] inositol phosphate (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts",IEPA.d17.s34,oxytocin,oxytocin
46,IEPA.d17,True,"The highest production of total inositol phosphates (d.p.m.) was found in cells from ovariectomized gilts given in vivo estradiol benzoate and progesterone for five consecutive days and treated with 1000 mU hCG and 100 mU hCG plus 1 microM oxytocin (984 +/- 84 and 1063 +/- 131 vs 314 +/- 36, respectively)",IEPA.d17.s35,inositol phosphates,oxytocin
47,IEPA.d17,True,"There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36,IP1,oxytocin
48,IEPA.d17,True,"There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36,IP1,oxytocin
49,IEPA.d17,True,"There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36,IP3,oxytocin
50,IEPA.d17,False,"There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36,IP1,IP1
51,IEPA.d17,False,"There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36,IP1,IP3
52,IEPA.d17,False,"There was also a very significant increase of IP1 after the addition of 1000 mU hCG (p < 0.001) and IP1 and IP3 when 1000 mU hCG plus oxytocin were added (p < 0.001 and p < 0.01, respectively)",IEPA.d17.s36,IP1,IP3
53,IEPA.d17,True,Only oxytocin alone increased the formation of IPs in cells from ovariectomized pigs treated with estradiol in vivo (p < 0.01),IEPA.d17.s37,oxytocin,IPs
54,IEPA.d17,True,The highest dose of hCG plus The highest dose of hCG plus oxytocin provoked accumulation of total [3H]inositol phosphate (p < 0.05) 53% over the basal level on days 21/1 of the estrous cycle,IEPA.d17.s38,oxytocin,inositol phosphate
55,IEPA.d17,True,The present study demonstrates that hCG and oxytocin can increase the accumulation of inositol phosphates in porcine myometrial cells,IEPA.d17.s39,oxytocin,inositol phosphates
56,IEPA.d18,False,"The relative risks between highest and lowest quarters of flavonoid intake adjusted for age, smoking, serum cholesterol concentration, blood pressure, and body mass index were 0.69 (95% confidence interval 0.53 to 0.90) and 0.54 (0.33 to 0.87) for total and coronary mortality, respectively",IEPA.d18.s40,flavonoid,cholesterol
57,IEPA.d19,False,"Granulosa cells were isolated from bovine preovulatory follicles and cultured for 3 days with or without OT in medium supplemented with either insulin (1 microgram/ml) + 1% fetal calf serum (FCS), which maintains basal estradiol secretion, or low doses of FSH (1 and 2 ng/ml) + 1% FCS, a culture condition that maximizes effects of FSH on estradiol secretion",IEPA.d19.s41,OT,insulin
58,IEPA.d20,True,"We propose that OT binds to specific OT receptors (OTR) on the endometrium to stimulate phosphoinositide (PI) hydrolysis, thereby activating the inositol trisphosphate (IP3)-diacylglycerol (DAG) second-messenger system to promote pulsatile PGF2 alpha secretion",IEPA.d20.s42,OT,IP3
59,IEPA.d20,True,Endometrial IP3 was increased within 30 seconds after OT treatment and preceded the increase in PGF2 alpha release stimulated by OT,IEPA.d20.s43,IP3,OT
60,IEPA.d20,False,Endometrial IP3 was increased within 30 seconds after OT treatment and preceded the increase in PGF2 alpha release stimulated by OT,IEPA.d20.s43,IP3,OT
61,IEPA.d20,False,Endometrial IP3 was increased within 30 seconds after OT treatment and preceded the increase in PGF2 alpha release stimulated by OT,IEPA.d20.s43,OT,OT
62,IEPA.d20,True,"These results support the hypothesis that OT stimulates phospholipase C to hydrolyze PI, yielding IP3 and DAG second-messengers which promote endometrial PGF2 alpha release during CL regression in pigs",IEPA.d20.s44,OT,IP3
63,IEPA.d21,True,These data suggest that cAMP-dependent phosphorylation at a step involving GTP-binding protein/PLC coupling can exert a negative effect on the stimulation of IP3 formation by oxytocin and thereby affect contraction/relaxation in the myometrium,IEPA.d21.s45,IP3,oxytocin
64,IEPA.d22,True,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,kinase
65,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,prion protein
66,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,prion protein
67,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,prion protein
68,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,kinase
69,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,prion protein
70,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,prion protein
71,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,kinase
72,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,prion protein
73,IEPA.d22,False,"Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase",IEPA.d22.s46,prion protein,kinase
74,IEPA.d23,True,"The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.",IEPA.d23.s47,prion protein,protein kinase
75,IEPA.d23,False,"The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.",IEPA.d23.s47,PrPsc,PrPc
76,IEPA.d23,False,"The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.",IEPA.d23.s47,PrPsc,prion protein
77,IEPA.d23,False,"The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.",IEPA.d23.s47,PrPsc,protein kinase
78,IEPA.d23,False,"The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.",IEPA.d23.s47,PrPc,prion protein
79,IEPA.d23,False,"The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.",IEPA.d23.s47,PrPc,protein kinase
80,IEPA.d24,True,"The aim of the present study was to investigate how oxytocin given subcutaneously (SC) and intracerebroventricularly (ICV) influences the secretion of insulin, glucagon and glucose and to investigate whether the effect on these variables of suckling in lactating rats is mediated by oxytocinergic mechanisms",IEPA.d24.s48,oxytocin,insulin
81,IEPA.d24,True,"Subcutaneous injections of oxytocin increased insulin, glucagon and glucose levels significantly",IEPA.d24.s49,oxytocin,insulin
82,IEPA.d24,True,Two nanograms oxytocin given ICV had no effect on glucagon and glucose levels but caused a significant rise in insulin levels at this time point,IEPA.d24.s50,oxytocin,insulin
83,IEPA.d24,True,The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate,IEPA.d24.s51,oxytocin,insulin
84,IEPA.d24,False,The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate,IEPA.d24.s51,oxytocin,insulin
85,IEPA.d24,False,The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate,IEPA.d24.s51,oxytocin,oxytocin
86,IEPA.d24,False,The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate,IEPA.d24.s51,oxytocin,insulin
87,IEPA.d24,False,The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate,IEPA.d24.s51,insulin,oxytocin
88,IEPA.d24,False,The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate,IEPA.d24.s51,insulin,insulin
89,IEPA.d24,True,Intracerebroventricular injections of 200 ng oxytocin caused a significant rise not only of insulin but also of glucagon and glucose levels,IEPA.d24.s52,oxytocin,insulin
90,IEPA.d24,True,"In contrast, nanogram amounts of oxytocin administered ICV cause a rise of insulin levels",IEPA.d24.s53,oxytocin,insulin
91,IEPA.d25,False,The responses of serum oxytocin (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an insulin (0.15 iu/kg as an i.v. bolus) tolerance test (ITT),IEPA.d25.s54,oxytocin,insulin
92,IEPA.d25,True,Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor OT response to insulin-induced hypoglycemia,IEPA.d25.s55,OT,insulin
93,IEPA.d26,False,"The SGR and RGR also had different endocrine profiles with, for example, twice as high oxytocin (p < 0.01) and insulin levels (p < 0.01) in RGR compared to the SGR",IEPA.d26.s56,oxytocin,insulin
94,IEPA.d27,True,"8-OH-DPAT also increased insulin and decreased CCK and somatostatin levels, effects that were blocked by pretreatment with the oxytocin antagonist",IEPA.d27.s57,insulin,oxytocin
95,IEPA.d27,True,"Taken together, these data suggest that the effect of 8-OH-DPAT on plasma levels of insulin, somatostatin and CCK may be mediated by oxytocin",IEPA.d27.s58,insulin,oxytocin
96,IEPA.d27,True,"In previous experiments, we have shown that following i.c.v. application of oxytocin, plasma levels of insulin are increased through a cholinergic mechanism",IEPA.d27.s59,oxytocin,insulin
97,IEPA.d28,True,"In HVSMC both oxytocin and AVP increased inositol 1,4,5-trisphosphate (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for oxytocin than AVP",IEPA.d28.s60,oxytocin,"inositol 1,4,5-trisphosphate"
98,IEPA.d28,False,"In HVSMC both oxytocin and AVP increased inositol 1,4,5-trisphosphate (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for oxytocin than AVP",IEPA.d28.s60,oxytocin,oxytocin
99,IEPA.d28,False,"In HVSMC both oxytocin and AVP increased inositol 1,4,5-trisphosphate (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for oxytocin than AVP",IEPA.d28.s60,"inositol 1,4,5-trisphosphate",oxytocin
100,IEPA.d31,True,"OT may rapidly stimulate inositol (1,4,5)-trisphosphate (IP3) and diacylglycerol (DAG) formation, consistent with the concept of rapid activation of a second-messenger system",IEPA.d31.s63,OT,"inositol (1,4,5)-trisphosphate"
101,IEPA.d31,True,"In support of this hypothesis, endometrial IP3 levels were increased (P < 0.05) within 0.5 min after treatment with 0.1 microM OT",IEPA.d31.s64,IP3,OT
102,IEPA.d31,True,These results indicate that OT induces endometrial IP3 production in a rapid manner indicative of a second-messenger system,IEPA.d31.s65,OT,IP3
103,IEPA.d32,True,Gamma-aminobutyric acid mediation of the inhibitory effect of nitric oxide on the arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia,IEPA.d32.s66,oxytocin,insulin
104,IEPA.d32,True,"Previous studies have demonstrated that the nitric oxide (NO) synthase inhibitor L-NAME exerts positive effects on the arginine vasopressin (AVP) and oxytocin (OT) responses to insulin-induced hypoglycemia, suggesting inhibitory actions of NO",IEPA.d32.s67,oxytocin,insulin
105,IEPA.d32,False,"AVP and OT secretory patterns during insulin (0.15 IU/kg, i.v.)-tolerance tests (ITT) were examined in seven normal male subjects with (experimental tests) and without (control test) concomitant treatment with L-NAME (40 micrograms/kg injected plus 50 micrograms/kg infused, i.v.), the GABAergic agent sodium valproate (600 mg in three divided doses orally) or the combination of L-NAME and sodium valproate",IEPA.d32.s68,OT,insulin
106,IEPA.d32,True,Insulin-induced hypoglycemia increased by 2-fold (peak vs. baseline) plasma AVP and OT levels,IEPA.d32.s69,Insulin,OT
107,IEPA.d32,True,These data indicate a GABAergic mediation of the inhibitory modulation by NO of the AVP and OT responses to insulin-induced hypoglycemia,IEPA.d32.s70,OT,insulin
108,IEPA.d33,True,Correlation between the stimulatory effect of oxytocin on the formation of inositol phosphates and the oxytocin receptor level in the pregnant rabbit myometrium,IEPA.d33.s71,oxytocin,inositol phosphates
109,IEPA.d33,True,"OBJECTIVE: In order to elucidate the roles of inositol trisphosphate (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of IP3 induced by OT and the OT receptor levels were determined in rabbit myometria before and after parturition",IEPA.d33.s72,IP3,OT
110,IEPA.d33,False,"OBJECTIVE: In order to elucidate the roles of inositol trisphosphate (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of IP3 induced by OT and the OT receptor levels were determined in rabbit myometria before and after parturition",IEPA.d33.s72,inositol trisphosphate,IP3
111,IEPA.d33,False,"OBJECTIVE: In order to elucidate the roles of inositol trisphosphate (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of IP3 induced by OT and the OT receptor levels were determined in rabbit myometria before and after parturition",IEPA.d33.s72,inositol trisphosphate,OT
112,IEPA.d33,False,"METHODS: The effects of OT on IP3 formation and OT receptor levels were determined in the myometria of non-pregnant rabbits, Days 26, 28 and 30 of pregnancy rabbits, postpartum rabbits within 12 hours and steroid-treated ovariectomized rabbits",IEPA.d33.s73,OT,IP3
113,IEPA.d33,True,"RESULTS: OT receptors were not detectable in the myometria of non-pregnant rabbits, and OT had no effect on the formation of inositol phosphates (IPs)",IEPA.d33.s74,OT,inositol phosphates
114,IEPA.d33,True,"On Day 28 of pregnancy, OT receptors became detectable, and then OT could induce the formation of IPs",IEPA.d33.s75,OT,IPs
115,IEPA.d33,True,"Thereafter, the stimulatory effects of OT on IPs formation and the OT receptor levels dramatically increased toward the end of pregnancy and reduced rapidly after parturition",IEPA.d33.s76,OT,IPs
116,IEPA.d33,True,"When the ovariectomized pregnant rabbits were treated with estrogen, OT receptors in the myometrium were induced, and OT acquired the ability to stimulate IP3 formation",IEPA.d33.s77,OT,IP3
117,IEPA.d33,True,"In addition, an OT receptor antagonist inhibited the stimulatory effects of OT on IP3 formation",IEPA.d33.s78,OT,IP3
118,IEPA.d33,True,"CONCLUSIONS: These results suggest that the formation of IPs by OT, the OT receptor levels in the myometrium, and the production of PGF2 in the decidua might play crucial roles in parturition",IEPA.d33.s79,IPs,OT
119,IEPA.d34,False,Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue,IEPA.d34.s80,leptin,uncoupling protein
120,IEPA.d34,False,"To establish the cell type expressing leptin, we also assessed the size and organization of lipid droplets, the ultrastructural features of mitochondria, and the presence or absence of uncoupling protein, a brown fat-specific marker",IEPA.d34.s81,leptin,uncoupling protein
121,IEPA.d34,False,"In brown adipose tissue of lean animals, multilocular uncoupling protein (UCP)-positive brown adipocytes had typical brown mitochondria and were leptin-negative, both in fed and fasted conditions",IEPA.d34.s82,uncoupling protein,leptin
122,IEPA.d34,False,"At the periphery of the interscapular brown adipose tissue depot, unilocular, UCP-negative adipocytes (mean diameter: 41.55 microns) with white-type mitochondria were observed, and these cells were leptin-positive",IEPA.d34.s83,UCP,leptin
123,IEPA.d34,False,"In obese (db/db) animals, brown fat was composed mainly of small unilocular, UCP-positive adipocytes (mean diameter: 40.08 microns), which were also leptin-positive",IEPA.d34.s84,UCP,leptin
124,IEPA.d34,False,"In summary, classical brown adipocytes differ from white adipocytes, not only by their morphology and UCP expression, but also by their apparent lack of detectable leptin expression",IEPA.d34.s85,UCP,leptin
125,IEPA.d36,False,Wortmannin converts insulin but not oxytocin from an antilipolytic to a lipolytic agent in the presence of forskolin,IEPA.d36.s87,insulin,oxytocin
126,IEPA.d36,False,"The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin",IEPA.d36.s88,insulin,oxytocin
127,IEPA.d36,False,"The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin",IEPA.d36.s88,insulin,insulin
128,IEPA.d36,False,"The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin",IEPA.d36.s88,oxytocin,insulin
129,IEPA.d36,False,"The antilipolytic effects of peroxovanadate and oxytocin were unaffected by 500 nmol/L wortmannin, which blocked the antilipolytic action of insulin",IEPA.d36.s89,oxytocin,insulin
130,IEPA.d36,False,The data provide additional support for the hypothesis that oxytocin and peroxovanadate affect adipose tissue metabolism by mechanisms distinctly different from those involved in insulin action,IEPA.d36.s90,oxytocin,insulin
131,IEPA.d37,False,"These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment insulin release from the beta cell, to increase phospholipase C-mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of insulin secretion",IEPA.d37.s91,insulin,phospholipase C
132,IEPA.d37,False,"These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment insulin release from the beta cell, to increase phospholipase C-mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of insulin secretion",IEPA.d37.s91,insulin,insulin
133,IEPA.d37,False,"These findings support the concept that the mitochondrial metabolism of nutrient molecules is an event sufficient to acutely augment insulin release from the beta cell, to increase phospholipase C-mediated phosphoinositide hydrolysis, and to induce time-dependent potentiation of insulin secretion",IEPA.d37.s91,phospholipase C,insulin
134,IEPA.d38,True,"2) IGF-1, IGF-2, and insulin also induced a Ca2+ mobilization from the endoplasmic reticulum: phospholipase C (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and insulin and totally inhibited the effect of IGF-2",IEPA.d38.s92,phospholipase C,insulin
135,IEPA.d38,False,"2) IGF-1, IGF-2, and insulin also induced a Ca2+ mobilization from the endoplasmic reticulum: phospholipase C (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and insulin and totally inhibited the effect of IGF-2",IEPA.d38.s92,insulin,phospholipase C
136,IEPA.d38,False,"2) IGF-1, IGF-2, and insulin also induced a Ca2+ mobilization from the endoplasmic reticulum: phospholipase C (PLC) inhibitors, neomycin, or U-73122 partially blocked the intracellular [Ca2+]i increase induced by IGF-1 and insulin and totally inhibited the effect of IGF-2",IEPA.d38.s92,insulin,insulin
137,IEPA.d39,False,Homogeneous liposome immunoassay for insulin using phospholipase C from Clostridium perfringens,IEPA.d39.s93,insulin,phospholipase C
138,IEPA.d39,False,"Insulin was conjugated to phospholipase C by a three-step procedure with hetero-bifunctional crosslinking reagents, succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate and 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester",IEPA.d39.s94,Insulin,phospholipase C
139,IEPA.d39,False,Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of insulin-phospholipase C conjugate were inhibited in the presence of insulin antiserum,IEPA.d39.s95,insulin,phospholipase C
140,IEPA.d39,False,Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of insulin-phospholipase C conjugate were inhibited in the presence of insulin antiserum,IEPA.d39.s95,insulin,insulin
141,IEPA.d39,False,Both p-nitrophenylphosphatidylcholine hydrolytic activity and liposome lytic activity of insulin-phospholipase C conjugate were inhibited in the presence of insulin antiserum,IEPA.d39.s95,phospholipase C,insulin
142,IEPA.d40,False,Roles of GTP and phospholipase C in the potentiation of Ca(2+)-induced insulin secretion by glucose in rat pancreatic islets,IEPA.d40.s96,phospholipase C,insulin
143,IEPA.d40,False,"There was a 98% greater augmentation of insulin secretion by 16.7 mM glucose (in the presence of diazoxide and 40 mM K+) in primed islets; however, the ability of high glucose to augment PLC activity bore no relationship to the secretory response",IEPA.d40.s97,insulin,PLC
144,IEPA.d40,False,"MPA markedly inhibited PLC in both conditions; however, insulin secretion was only inhibited (by 46%) in primed islets",IEPA.d40.s98,PLC,insulin
145,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion,IEPA.d40.s99,insulin,PLC
146,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion,IEPA.d40.s99,insulin,insulin
147,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion,IEPA.d40.s99,insulin,insulin
148,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion,IEPA.d40.s99,PLC,insulin
149,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion,IEPA.d40.s99,PLC,insulin
150,IEPA.d40,False,These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion,IEPA.d40.s99,insulin,insulin
151,IEPA.d41,True,Regulation of insulin secretion via ATP-sensitive K+ channel independent mechanisms: role of phospholipase C,IEPA.d41.s100,insulin,phospholipase C
152,IEPA.d41,True,"The further addition of carbachol, an agonist that activates an isozyme of phospholipase C distinct from that activated by glucose, together with K+, 20 mM glucose, plus diazoxide resulted in a sustained amplification of insulin secretion from mouse but not rat islets",IEPA.d41.s101,phospholipase C,insulin
153,IEPA.d41,True,"The inability to activate a nutrient- and calcium-regulated phospholipase C isozyme in mouse islets to the same extent as in rat islets appears to account, at least in part, for these different insulin secretory responses under these unique conditions",IEPA.d41.s102,phospholipase C,insulin
154,IEPA.d43,True,Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation,IEPA.d43.s108,leptin,uncoupling protein-2
155,IEPA.d43,True,Here we show that leptin alters in pancreatic islets the mRNA of the genes encoding enzymes of free fatty acid metabolism and uncoupling protein-2 (UCP-2),IEPA.d43.s109,leptin,uncoupling protein-2
156,IEPA.d43,True,"Leptin overexpression increased UCP-2 mRNA by more than 10-fold in epididymal, retroperitoneal, and subcutaneous fat tissue of normal, but not of leptin-receptor-defective obese rats",IEPA.d43.s110,Leptin,UCP-2
157,IEPA.d43,True,"By directly regulating the expression of enzymes of free fatty acid metabolism and of UCP-2, leptin controls intracellular triglyceride content of certain nonadipocytes, as well as adipocytes",IEPA.d43.s111,UCP-2,leptin
158,IEPA.d44,False,"Further, the oxytocin-induced activation of IK(sl) was effectively antagonized by 5 x 10(-8) mol/l U-73122 or 5 x 10(-6) mol/l 2-nitro-4-carboxyphenyl N,N-diphenylcarbamate (inhibitors of the cell membrane phospholipase C), as well as by intracellularly applied heparin (selective inhibitor of inositol-1,4,5-trisphosphate (IP3)-induced Ca2+ release channels)",IEPA.d44.s112,oxytocin,"inositol-1,4,5-trisphosphate"
159,IEPA.d44,False,"The data obtained suggest (i) that selective oxytocin receptors are present on the membranes of guinea-pig antral smooth muscle cells, (ii) that the oxytocin-related relaxation may result from the activation of Ca(2+)-sensitive K+ conductivity via activation of IP3-induced release of Ca2+ from the submembrane located cisternae of the sarcoplasmic reticulum Ca2+ stores and (iii) in turn, this evokes a non-inactivating component of IK, hyperpolarizing the cell membrane",IEPA.d44.s113,oxytocin,IP3
160,IEPA.d45,False,"Cellular preincubation with 200 microg/ml antibodies against the inositolphosphoglycan (IPG) moiety of the GPI-anchor (Ab(IPG)), or depletion in GPI-anchored proteins by cellular pretreatment with 0.5 U/ml PI-PLC, 1 mM insulin and 2 HU/ml streptolysin-O, or depletion in membrane cholesterol content by filipin (5 microg/ml), digitonin (5 microg/ml) and cholesterol oxidase (0.5 U/ml) decreases the HDL3-signal, suggesting the involvement of a lipolytic cleavage of GPI-anchored proteins",IEPA.d45.s114,PLC,insulin
161,IEPA.d48,True,Leptin increases uncoupling protein expression and energy expenditure,IEPA.d48.s123,Leptin,uncoupling protein
162,IEPA.d48,True,Leptin increased BAT UCP mRNA levels greater than twofold in both ad libitum-fed and food-restricted rats,IEPA.d48.s124,Leptin,UCP
163,IEPA.d48,True,"These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP",IEPA.d48.s125,leptin,UCP
164,IEPA.d48,False,"These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP",IEPA.d48.s125,leptin,leptin
165,IEPA.d48,False,"These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP",IEPA.d48.s125,leptin,UCP
166,IEPA.d52,True,"Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin",IEPA.d52.s135,Uncoupling protein-3,leptin
167,IEPA.d52,True,"UCP3 mRNA levels were also regulated by dexamethasone, leptin, and starvation, albeit differently in muscle and brown adipose tissue",IEPA.d52.s136,UCP3,leptin
168,IEPA.d54,False,"This effect is maximal at 10(-8) M AVP (a concentration clearly above the normal physiological range of AVP concentrations) and involves the V2 receptor pathway, while activation of protein kinase C or changes in intracellular calcium are ineffective",IEPA.d54.s138,AVP,AVP
169,IEPA.d54,False,"This effect is maximal at 10(-8) M AVP (a concentration clearly above the normal physiological range of AVP concentrations) and involves the V2 receptor pathway, while activation of protein kinase C or changes in intracellular calcium are ineffective",IEPA.d54.s138,AVP,protein kinase C
170,IEPA.d54,False,"This effect is maximal at 10(-8) M AVP (a concentration clearly above the normal physiological range of AVP concentrations) and involves the V2 receptor pathway, while activation of protein kinase C or changes in intracellular calcium are ineffective",IEPA.d54.s138,AVP,protein kinase C
171,IEPA.d55,False,"After protein kinase C activity was functionally depleted by treating cells with phorbol 12-myristate 13-acetate for 24 hours, AVP did not augment IL-1beta-induced NO production",IEPA.d55.s139,protein kinase C,AVP
172,IEPA.d55,True,The effect of AVP was also inhibited in the presence of the protein kinase C inhibitor calphostin C,IEPA.d55.s140,AVP,protein kinase C
173,IEPA.d55,True,"The addition of AVP increased protein kinase C activity in cardiac myocytes, and its effect was significantly inhibited in the presence of calphostin C",IEPA.d55.s141,AVP,protein kinase C
174,IEPA.d55,True,"These results support the hypothesis that the heart may be a target organ for AVP and that AVP modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of protein kinase C",IEPA.d55.s142,AVP,protein kinase C
175,IEPA.d55,False,"These results support the hypothesis that the heart may be a target organ for AVP and that AVP modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of protein kinase C",IEPA.d55.s142,AVP,AVP
176,IEPA.d55,False,"These results support the hypothesis that the heart may be a target organ for AVP and that AVP modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of protein kinase C",IEPA.d55.s142,AVP,protein kinase C
177,IEPA.d57,True,Activation of EGFR overexpressing 3T3-L1 adipocytes leads to a 3.4 +/- 1.2-fold stimulation of PLC activity over basal levels vs. only 1.06 +/- 0.01-fold stimulation by insulin.,IEPA.d57.s146,PLC,insulin
178,IEPA.d57,True,"Despite the low levels of insulin-induced PLC activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)",IEPA.d57.s147,insulin,PLC
179,IEPA.d57,False,"Despite the low levels of insulin-induced PLC activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)",IEPA.d57.s147,insulin,insulin
180,IEPA.d57,False,"Despite the low levels of insulin-induced PLC activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)",IEPA.d57.s147,PLC,insulin
181,IEPA.d57,False,"Inhibition of PLC activation did not impair either EGF- or insulin-induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and insulin-induced glucose disposal can be independent of GLUT4-mediated glucose transport.",IEPA.d57.s148,PLC,insulin
182,IEPA.d57,False,"Inhibition of PLC activation did not impair either EGF- or insulin-induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and insulin-induced glucose disposal can be independent of GLUT4-mediated glucose transport.",IEPA.d57.s148,PLC,insulin
183,IEPA.d57,False,"Inhibition of PLC activation did not impair either EGF- or insulin-induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and insulin-induced glucose disposal can be independent of GLUT4-mediated glucose transport.",IEPA.d57.s148,insulin,insulin
184,IEPA.d57,False,The diminution of glucose transport secondary to inhibition of PLC activity was reflected by a decrease in GLUT4 translocation to the plasma membrane upon either EGF or insulin stimulation,IEPA.d57.s149,PLC,insulin
185,IEPA.d58,True,We have recently shown that AVP causes a protein kinase C (PKC)-dependent increase in ACTH release and biosynthesis in ovine anterior pituitary cells,IEPA.d58.s150,AVP,protein kinase C
186,IEPA.d58,True,"In these cells, AVP also causes the translocation of PKC from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to protein kinase C activation that underlie ACTH secretion have not been well characterized to date",IEPA.d58.s151,AVP,PKC
187,IEPA.d58,False,"In these cells, AVP also causes the translocation of PKC from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to protein kinase C activation that underlie ACTH secretion have not been well characterized to date",IEPA.d58.s151,AVP,protein kinase C
188,IEPA.d58,False,"In these cells, AVP also causes the translocation of PKC from the cytosol to the cell membrane which is maximal at 5 min, but the intracellular events distal to protein kinase C activation that underlie ACTH secretion have not been well characterized to date",IEPA.d58.s151,PKC,protein kinase C
189,IEPA.d58,False,"Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PKC in synaptosomes, studies were carried out to determine whether AVP might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PKC translocation and the release of ACTH",IEPA.d58.s152,PKC,AVP
190,IEPA.d58,False,"Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PKC in synaptosomes, studies were carried out to determine whether AVP might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PKC translocation and the release of ACTH",IEPA.d58.s152,PKC,PKC
191,IEPA.d58,False,"Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PKC in synaptosomes, studies were carried out to determine whether AVP might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PKC translocation and the release of ACTH",IEPA.d58.s152,AVP,PKC
192,IEPA.d58,False,"We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153,AVP,AVP
193,IEPA.d58,False,"We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153,AVP,PKC
194,IEPA.d58,False,"We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153,AVP,PKC
195,IEPA.d58,False,"We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153,AVP,PKC
196,IEPA.d58,False,"We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153,AVP,PKC
197,IEPA.d58,False,"We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.",IEPA.d58.s153,PKC,PKC
198,IEPA.d60,True,"The activity of the MAPKs, induced by AVP or PMA was inhibited by downregulation of protein kinase C (PKC), by the tyrosine kinase inhibitor genistein and by MAPK kinase (MEK) inhibitor, PD98059",IEPA.d60.s155,AVP,protein kinase C
199,IEPA.d60,True,"We suggest that AVP activates the 42/44kDa MAPKs through a signal transduction pathway that involves stimulation of AVP-V1 receptor, tyrosine kinase, PKC and MEK",IEPA.d60.s156,AVP,PKC
200,IEPA.d61,True,Secreted form of beta-amyloid precursor protein activates protein kinase C and phospholipase Cgamma1 in cultured embryonic rat neocortical cells,IEPA.d61.s157,beta-amyloid,phospholipase Cgamma1
201,IEPA.d61,True,"Furthermore, we demonstrate that tyrosine phosphorylation of phospholipase Cgamma1 and formation of inositol 1,4,5-trisphosphate were increased by sAPP695-stimulation",IEPA.d61.s158,phospholipase Cgamma1,sAPP695
202,IEPA.d62,True,"Oxytocin-treated male rats had increased circulating levels of cholecystokinin, a tendency to increased plasma levels of insulin (p = 0.066), and relatively more adipose tissue in the thigh and interscapular region, compared with controls",IEPA.d62.s159,Oxytocin,insulin
203,IEPA.d63,True,"However, in brown fat, we observed a 2-3-fold increase in the expression of UCP1 in response to dietary fat challenge, which may be related to diet-induced elevations in plasma leptin levels",IEPA.d63.s160,UCP1,leptin
204,IEPA.d65,True,Vasopressin-induced activation of protein kinase C in renal epithelial cells,IEPA.d65.s163,Vasopressin,protein kinase C
205,IEPA.d65,True,"AVP induced a biphasic increase in diacylglycerol generation, characterized by an initial rapid rise and then a sustained elevation, and PKC activation, reflected by phosphorylation of a specific 80 kDa myristoylated alanine-rich PKC substrate (MARCKS)",IEPA.d65.s164,AVP,PKC
206,IEPA.d65,True,"These results argue that Ca(2+)-dependent PKC is involved in the action of AVP, and that of other agonists, which stimulate sodium transport",IEPA.d65.s165,PKC,AVP
207,IEPA.d66,True,"However, the AVP-dependent stimulation required activation of protein kinase C (PKC), whereas the inhibition was PKC independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct",IEPA.d66.s166,AVP,protein kinase C
208,IEPA.d66,False,"However, the AVP-dependent stimulation required activation of protein kinase C (PKC), whereas the inhibition was PKC independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct",IEPA.d66.s166,AVP,PKC
209,IEPA.d66,False,"However, the AVP-dependent stimulation required activation of protein kinase C (PKC), whereas the inhibition was PKC independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct",IEPA.d66.s166,protein kinase C,PKC
210,IEPA.d67,True,Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin,IEPA.d67.s167,PLCgamma,insulin
211,IEPA.d67,False,Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin,IEPA.d67.s167,phospholipase C-gamma,PLCgamma
212,IEPA.d67,False,Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin,IEPA.d67.s167,phospholipase C-gamma,insulin
213,IEPA.d67,False,"To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation",IEPA.d67.s168,PLCgamma,PLC
214,IEPA.d67,False,"To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation",IEPA.d67.s168,PLCgamma,PLCgamma
215,IEPA.d67,False,"To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation",IEPA.d67.s168,PLCgamma,insulin
216,IEPA.d67,False,"To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation",IEPA.d67.s168,PLC,PLCgamma
217,IEPA.d67,False,"To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation",IEPA.d67.s168,PLC,insulin
218,IEPA.d67,False,"To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation",IEPA.d67.s168,PLCgamma,insulin
219,IEPA.d70,True,Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and OT and the OT response to insulin-induced hypoglycemia,IEPA.d70.s171,OT,insulin
220,IEPA.d70,False,Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and OT and the OT response to insulin-induced hypoglycemia,IEPA.d70.s171,OT,OT
221,IEPA.d70,False,Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and OT and the OT response to insulin-induced hypoglycemia,IEPA.d70.s171,OT,insulin
222,IEPA.d71,True,HvSPY coexpression largely abolished GA3-induced activity of an alpha-amylase promoter.,IEPA.d71.s172,GA3,alpha-amylase
223,IEPA.d72,True,"Treatment with (+)-trifluoro-ABA strongly inhibited the gibberellic acid-inducible expression of alpha-amylase I-1 encoded by RAmy1A in the aleurone layers of embryoless half-seeds at the levels of transcription, protein synthesis, and enzyme activity",IEPA.d72.s173,gibberellic acid,alpha-amylase
224,IEPA.d73,False,"Furthermore, treatment of isolated rat diaphragms and adipocytes with PIG-P as well as with other agents exerting partially insulin-mimetic activity, such as PI-specific phospholipase C (PLC) and the sulfonylurea glimepiride, triggered tyrosine phosphorylation of the caveolar marker protein caveolin, which was apparently correlated with stimulation of lipogenesis",IEPA.d73.s174,insulin,phospholipase C
225,IEPA.d73,False,"Strikingly, in adipocytes subjected to combined trypsin/salt treatment, PIG-P, PI-specific PLC, and glimepiride failed completely to provoke insulin-mimetic effects",IEPA.d73.s175,PLC,insulin
226,IEPA.d74,True,Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins,IEPA.d74.s176,leptin,uncoupling proteins
227,IEPA.d74,True,"In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues",IEPA.d74.s177,leptin,UCP1
228,IEPA.d74,True,"In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues",IEPA.d74.s177,leptin,UCP2
229,IEPA.d74,True,"In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues",IEPA.d74.s177,leptin,UCP3
230,IEPA.d74,False,"In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues",IEPA.d74.s177,UCP1,UCP2
231,IEPA.d74,False,"In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues",IEPA.d74.s177,UCP1,UCP3
232,IEPA.d74,False,"In marked contrast, intracerebroventricular leptin administration was accompanied by the maintenance of high UCP1, UCP2, and UCP3 expression in all these tissues",IEPA.d74.s177,UCP2,UCP3
233,IEPA.d74,True,"While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats",IEPA.d74.s178,leptin,UCP1
234,IEPA.d74,True,"While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats",IEPA.d74.s178,leptin,UCP2
235,IEPA.d74,True,"While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats",IEPA.d74.s178,leptin,UCP3
236,IEPA.d74,False,"While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats",IEPA.d74.s178,UCP1,UCP2
237,IEPA.d74,False,"While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats",IEPA.d74.s178,UCP1,UCP3
238,IEPA.d74,False,"While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats",IEPA.d74.s178,UCP2,UCP3
239,IEPA.d76,True,"Melatonin inhibits oxytocin response to insulin-induced hypoglycemia, but not to angiotensin II in normal men",IEPA.d76.s182,oxytocin,insulin
240,IEPA.d76,False,"In order to establish whether melatonin alters basal and/or stimulated oxytocin secretion, 18 normal men were treated (p.o.) with 6 or 12 mg melatonin or placebo in basal conditions (N-6 subjects) or concomitantly to the administration of insulin (O.15 IU/kg body weight in an i.v. bolus) (N-6 subjects) or angiotensin II (increasing doses of 4, 8 and 16 ng/kg/min, at intervals of 20 min)",IEPA.d76.s183,oxytocin,insulin
241,IEPA.d76,True,"In contrast, the oxytocin response to insulin-induced hypoglycemia was significantly reduced by melatonin treatment",IEPA.d76.s184,oxytocin,insulin
242,IEPA.d77,False,"Although osmotic stimuli cause an increase in nitric oxide synthase (NOS) activity as well as synthesis of AVP and oxytocin in the paraventricular (PVN) and supraoptic nuclei (SON), it is not known whether NOS activity in the hypothalamus changes in the diabetic patients who have plasma hyperosmolality with hyperglycaemia caused by insulin deficiency",IEPA.d77.s185,oxytocin,insulin
243,IEPA.d77,True,"Three weeks after administration of STZ, the diabetic rats were subcutaneously treated with insulin for 1 week, which resulted in significant suppression of the induction of nNOS, AVP and oxytocin gene expression in the PVN and SON",IEPA.d77.s186,insulin,oxytocin
244,IEPA.d79,False,OT evokes the release of Ca2+ from IP3-sensitive intracellular stores,IEPA.d79.s189,OT,IP3
245,IEPA.d80,False,"To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats",IEPA.d80.s190,leptin,leptin
246,IEPA.d80,False,"To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats",IEPA.d80.s190,leptin,uncoupling protein-1
247,IEPA.d80,False,"To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats",IEPA.d80.s190,leptin,uncoupling protein-1
248,IEPA.d80,True,"A single i.c.v. injection of leptin decreased cumulative food intake and body weight gain, and increased UCP-1 mRNA expression during 3 h at the onset of the dark phase",IEPA.d80.s191,leptin,UCP-1
249,IEPA.d80,True,Co-injection of SHU9119 also inhibited completely the leptin-induced increase in UCP-1 mRNA expression in the BAT,IEPA.d80.s192,leptin,UCP-1
250,IEPA.d81,True,"It has been established that amyloid beta peptide (AbetaP) activates phospholipase A2, phospholipase C and phospholipase D of LA-N-2 cells and other cell types",IEPA.d81.s193,amyloid,phospholipase C
251,IEPA.d81,True,(-)Nicotine did not blunt the AbetaP activation of phospholipase C,IEPA.d81.s194,AbetaP,phospholipase C
252,IEPA.d82,True,Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein,IEPA.d82.s195,leptin,uncoupling protein
253,IEPA.d82,False,"NPY in the PVN increases feeding and decreases uncoupling protein (UCP) activity in brown fat, whereas leptin decreases NPY biosynthesis in the Arc, which presumably decreases PVN NPY",IEPA.d82.s196,uncoupling protein,leptin
254,IEPA.d82,True,"Next, we determined that leptin decreases NPY and increases UCP gene expression",IEPA.d82.s197,leptin,UCP
255,IEPA.d83,False,"Furthermore, immunocytochemical studies showed the A beta-induced neuronal MAC expression on the SH-SY5Y cells after CD59 was removed by PIPLC or blocked by anti-CD59 antibody",IEPA.d83.s198,A beta,PIPLC
256,IEPA.d84,True,Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics,IEPA.d84.s199,insulin,oxytocin
257,IEPA.d84,False,Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics,IEPA.d84.s199,insulin,insulin
258,IEPA.d84,False,Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics,IEPA.d84.s199,oxytocin,insulin
259,IEPA.d84,True,"Since previous studies showed that AVP secretion is influenced by the persistence of residual endogenous insulin secretion, we wondered whether this factor also regulates OT secretion",IEPA.d84.s200,insulin,OT
260,IEPA.d84,True,DESIGN: Case-control study: the OT response to insulin-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous insulin secretion,IEPA.d84.s201,OT,insulin
261,IEPA.d84,False,DESIGN: Case-control study: the OT response to insulin-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous insulin secretion,IEPA.d84.s201,OT,insulin
262,IEPA.d84,False,DESIGN: Case-control study: the OT response to insulin-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous insulin secretion,IEPA.d84.s201,insulin,insulin
263,IEPA.d84,False,"Blood samples for OT assay were taken just before the rapid injection of insulin (time 0) and at time 15, 30, 45 and 60 min",IEPA.d84.s202,OT,insulin
264,IEPA.d84,True,CONCLUSIONS: These data indicate that a residual endogenous insulin secretion exerts a partial protective action against the hypothalamic-pituitary disorder affecting the OT secretory system in IDDM,IEPA.d84.s203,insulin,OT
265,IEPA.d85,True,A barley gene encoding a novel DNA-binding protein (HRT) was identified by southwestern screening with baits containing a gibberellin phytohormone response element from an alpha-amylase promoter,IEPA.d85.s204,gibberellin,alpha-amylase
266,IEPA.d86,True,"These observations suggest that bradykinin, like oxytocin, activates phospholipase C which generates IP3 with a subsequent release of Ca2+ from intracellular stores followed by store-operated Ca2+ influx",IEPA.d86.s205,oxytocin,IP3
267,IEPA.d87,True,"These findings led us to conclude that inositol trisphosphate [corrected] causes Ca2+ mobilization by muscarinic activation of PLC, leading to intracellular translocation of insulin granules to the ready-releasable pool in pancreatic beta-cells via Ca2+/calmodulin-dependent phosphorylation of myosin light chains",IEPA.d87.s206,PLC,insulin
268,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP3,UCP2
269,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP3,leptin
270,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP3,UCP3
271,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP3,UCP2
272,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP2,leptin
273,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP2,UCP3
274,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP2,UCP2
275,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,leptin,UCP3
276,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,leptin,UCP2
277,IEPA.d88,False,"To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative",IEPA.d88.s207,UCP3,UCP2
278,IEPA.d88,False,"These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro",IEPA.d88.s208,UCP3,leptin
279,IEPA.d88,False,"These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro",IEPA.d88.s208,UCP3,UCP3
280,IEPA.d88,False,"These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro",IEPA.d88.s208,leptin,UCP3
281,IEPA.d89,True,"UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin",IEPA.d89.s209,UCP2,leptin
282,IEPA.d89,True,"UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin",IEPA.d89.s209,UCP3,leptin
283,IEPA.d89,False,"UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin",IEPA.d89.s209,UCP2,UCP3
284,IEPA.d89,False,"UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin",IEPA.d89.s209,UCP2,leptin
285,IEPA.d89,False,"UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin",IEPA.d89.s209,UCP3,leptin
286,IEPA.d89,False,"UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin",IEPA.d89.s209,leptin,leptin
287,IEPA.d89,False,"To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats",IEPA.d89.s210,leptin,leptin
288,IEPA.d89,False,"To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats",IEPA.d89.s210,leptin,uncoupling proteins
289,IEPA.d89,False,"To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats",IEPA.d89.s210,leptin,uncoupling proteins
290,IEPA.d89,True,"Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT",IEPA.d89.s211,Leptin,UCP1
291,IEPA.d89,True,"Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT",IEPA.d89.s211,Leptin,UCP3
292,IEPA.d89,True,"Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT",IEPA.d89.s211,Leptin,UCP2
293,IEPA.d89,False,"Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT",IEPA.d89.s211,UCP1,UCP3
294,IEPA.d89,False,"Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT",IEPA.d89.s211,UCP1,UCP2
295,IEPA.d89,False,"Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT",IEPA.d89.s211,UCP3,UCP2
296,IEPA.d89,True,"The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212,leptin,UCP2
297,IEPA.d89,True,"The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212,leptin,UCP1
298,IEPA.d89,True,"The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212,leptin,UCP3
299,IEPA.d89,False,"The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212,UCP2,UCP1
300,IEPA.d89,False,"The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212,UCP2,UCP3
301,IEPA.d89,False,"The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT",IEPA.d89.s212,UCP1,UCP3
302,IEPA.d90,True,DNase1 footprints suggest the involvement of at least three types of transcription factors in the regulation of alpha-Amy2/A by gibberellin,IEPA.d90.s213,alpha-Amy2/A,gibberellin
303,IEPA.d90,True,The regulation of alpha-Amy2 genes by GA therefore involves an interplay of at least three different types of transcription factor,IEPA.d90.s214,alpha-Amy2,GA
304,IEPA.d91,True,Oxytocin-stimulated insulin release in a clonal beta-cell line RINm5F: involvement of phospholipase C-dependent and -independent pathways.,IEPA.d91.s215,insulin,phospholipase C
305,IEPA.d91,True,CONCLUSION: Oxy increases insulin release through both PLC and non-PLC mediated signal transduction mechanisms.,IEPA.d91.s216,insulin,PLC
306,IEPA.d91,True,"In addition, U-73122 diminished the Oxy-induced increase in intracellular concentration of inositol 1, 4, 5-triphosphate (IP3)",IEPA.d91.s217,Oxy,"inositol 1, 4, 5-triphosphate"
307,IEPA.d91,True,"U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s218,Oxy,IP3
308,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s218,Oxy,Oxy
309,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s218,IP3,Oxy
310,IEPA.d91,True,Oxytocin-stimulated insulin release in a clonal beta-cell line RINm5F: involvement of phospholipase C-dependent and -independent pathways,IEPA.d91.s219,Oxytocin,insulin
311,IEPA.d91,True,AIM: To study the mechanisms underlying oxytocin (Oxy)-induced insulin release,IEPA.d91.s220,oxytocin,insulin
312,IEPA.d91,True,RESULTS: Oxy increased insulin release and [Ca2+]i in a concentration-dependent manner,IEPA.d91.s221,Oxy,insulin
313,IEPA.d91,True,Oxy-induced insulin release was not altered by pretreatment with pertussis toxin (PT),IEPA.d91.s222,Oxy,insulin
314,IEPA.d91,True,"U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s223,Oxy,insulin
315,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s223,Oxy,Oxy
316,IEPA.d91,False,"U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively",IEPA.d91.s223,Oxy,insulin
317,IEPA.d91,True,CONCLUSION: Oxy increases insulin release through both PLC and non-PLC mediated signal transduction mechanisms,IEPA.d91.s224,Oxy,insulin
318,IEPA.d92,False,"In isolated adipocytes, the loss of almost half the 18S RNA content over a 24-hour incubation was prevented in the presence of insulin but not oxytocin or epidermal growth factor (EGF)",IEPA.d92.s225,insulin,oxytocin
319,IEPA.d93,True,"Further investigation suggested that activation of protein kinase C (PKC), which is part of the AVP-induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for AVP-induced ACTH release",IEPA.d93.s226,protein kinase C,AVP
320,IEPA.d93,False,"Further investigation suggested that activation of protein kinase C (PKC), which is part of the AVP-induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for AVP-induced ACTH release",IEPA.d93.s226,protein kinase C,AVP
321,IEPA.d93,False,"Further investigation suggested that activation of protein kinase C (PKC), which is part of the AVP-induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for AVP-induced ACTH release",IEPA.d93.s226,AVP,AVP
322,IEPA.d94,False,"Oxytocin (OT) is more expressed in the TEC/TNC than vasopressin (VP); insulin-like growth factor 2 (IGF-2) thymic expression predominates over IGF-1, and much more over (pro)insulin",IEPA.d94.s227,Oxytocin,(pro)insulin
323,IEPA.d94,False,"Thus, OT was proposed to be the self antigen of the neurohypophysial family, and IGF-2 the self antigen precursor of the insulin family",IEPA.d94.s228,OT,insulin
324,IEPA.d96,True,Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment,IEPA.d96.s231,uncoupling protein 2,leptin
325,IEPA.d96,True,Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment,IEPA.d96.s231,uncoupling protein 3,leptin
326,IEPA.d96,False,Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment,IEPA.d96.s231,uncoupling protein 2,uncoupling protein 3
327,IEPA.d96,True,Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%),IEPA.d96.s232,Leptin,UCP-2
328,IEPA.d96,True,Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%),IEPA.d96.s232,Leptin,UCP-3
329,IEPA.d96,False,Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%),IEPA.d96.s232,UCP-2,UCP-3
330,IEPA.d96,False,"Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM",IEPA.d96.s233,UCP-2,UCP-3
331,IEPA.d96,False,"Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM",IEPA.d96.s233,UCP-2,leptin
332,IEPA.d96,False,"Denervation suppressed mRNA levels for UCP-2 (49%), UCP-3 (36%), and COX-IV (59%) and eliminated the acute response to leptin in SM",IEPA.d96.s233,UCP-3,leptin
333,IEPA.d97,True,"The specific protein kinase C (PKC) inhibitor chelerythrine (5 micrometers) inhibited PTH-, AVP-, PGE2-, and adenosine-stimulated Ca2+ reabsorption by 77%, 67%, 79%, and 100%, respectively",IEPA.d97.s234,protein kinase C,AVP
334,IEPA.d97,True,"CONCLUSION: PTH, AVP, PGE2, and adenosine stimulate Ca2+ reabsorption via a pathway that is independent of cAMP and that involves a phorbol ester-insensitive PKC isotype",IEPA.d97.s235,AVP,PKC
335,IEPA.d98,True,We observed that primary microglial cultures and the THP-1 monocytic cell line are stimulated by fibrillar beta-amyloid and prion peptides to activate identical tyrosine kinase-dependent inflammatory signal transduction cascades,IEPA.d98.s236,prion,tyrosine kinase
336,IEPA.d99,True,Enhanced phosphoinositide hydrolysis via overexpression of phospholipase C beta1 or delta1 inhibits stimulus-induced insulin release in insulinoma MIN6 cells.,IEPA.d99.s237,phospholipase C,insulin
337,IEPA.d99,False,"To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.",IEPA.d99.s238,insulin,phospholipase Cbeta1
338,IEPA.d99,False,"To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.",IEPA.d99.s238,insulin,PLCdelta1
339,IEPA.d99,False,"To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.",IEPA.d99.s238,phospholipase Cbeta1,PLCdelta1
340,IEPA.d100,True,"If daily oxytocin injections are repeated over a 5-day period, blood pressure is decreased by 10-20 mmHg, the withdrawal latency to heat stimuli is prolonged, cortisol levels are decreased and insulin and cholecystokinin levels are increased",IEPA.d100.s239,oxytocin,insulin
341,IEPA.d104,False,"In addition, abscisic acid-mediated inhibition of gibberellin-stimulated responses seems to depend on the activation of a phospholipase D during induction of alpha-amylase in barley aleurone cells as well as on a putative acetyltransferase involved in elongation growth.",IEPA.d104.s243,gibberellin,alpha-amylase
342,IEPA.d106,True,"Protein kinase C (PKC) inhibitors reversed AVP inhibition, whereas PKC activator inhibited nitrite production",IEPA.d106.s245,Protein kinase C,AVP
343,IEPA.d106,False,"Protein kinase C (PKC) inhibitors reversed AVP inhibition, whereas PKC activator inhibited nitrite production",IEPA.d106.s245,Protein kinase C,PKC
344,IEPA.d106,False,"Protein kinase C (PKC) inhibitors reversed AVP inhibition, whereas PKC activator inhibited nitrite production",IEPA.d106.s245,AVP,PKC
345,IEPA.d106,True,The inhibitory action of AVP involves both the activation of PKC and the transcription of iNOS mRNA in cultured rat GMC,IEPA.d106.s246,AVP,PKC
346,IEPA.d107,True,Molecular characterization of catalytic-subunit cDNA sequences encoding protein phosphatases 1 and 2A and study of their roles in the gibberellin-dependent Osamy-c expression in rice,IEPA.d107.s247,gibberellin,Osamy-c
347,IEPA.d107,True,"To understand the molecular mechanism of gibberellin-dependent gene regulation, the effect of three phosphatase inhibitors on the germination of rice seeds and the expression of a target gene, the alpha-amylase gene, Osamy-c, were measured",IEPA.d107.s248,gibberellin,alpha-amylase
348,IEPA.d107,True,"To further understand the possible role of protein phosphatases 1 and 2A in the GA-dependent expression of Osamy-c, we isolated cDNA clones encoding protein phosphatase 1 and protein phosphatase 2A from a rice aleurone cDNA library",IEPA.d107.s249,GA,Osamy-c
349,IEPA.d107,True,"Taken together, our results suggest that protein phosphatases PP1 or PP2A are involved in the GA-dependent expression of the rice Osamy-c gene, though the PP1 or/and PP2A enzymatic activities as well as mRNA levels do not increase upon GA3 treatment",IEPA.d107.s250,GA,Osamy-c
350,IEPA.d109,True,Fasting and leptin modulate adipose and muscle uncoupling protein: divergent effects between messenger ribonucleic acid and protein expression,IEPA.d109.s256,leptin,uncoupling protein
351,IEPA.d109,False,"In this study, we examined the effects of fasting for 2 days and exogenous s.c. leptin, 200 microg every 8 h for 2 days, on the regulation of uncoupling protein (UCP) subtypes in brown adipose tissue (BAT) and gastrocnemius muscle",IEPA.d109.s257,leptin,uncoupling protein
352,IEPA.d109,False,"Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats",IEPA.d109.s258,Leptin,UCP-1
353,IEPA.d109,False,"Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats",IEPA.d109.s258,Leptin,UCP-3
354,IEPA.d109,False,"Leptin, compared with vehicle, did not alter BAT UCP-1 or UCP-3 mRNA or protein expression when administered to normal ad libitum fed rats",IEPA.d109.s258,UCP-1,UCP-3
355,IEPA.d109,True,"Fasting significantly decreased BAT UCP-1 and UCP-3 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of leptin to fasted rats",IEPA.d109.s259,UCP-1,leptin
356,IEPA.d109,True,"Fasting significantly decreased BAT UCP-1 and UCP-3 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of leptin to fasted rats",IEPA.d109.s259,UCP-3,leptin
357,IEPA.d109,False,"Fasting significantly decreased BAT UCP-1 and UCP-3 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of leptin to fasted rats",IEPA.d109.s259,UCP-1,UCP-3
358,IEPA.d109,False,"Fasting also significantly decreased BAT UCP-1 protein expression, to 67% of control; however, that effect was not prevented by leptin treatment",IEPA.d109.s260,UCP-1,leptin
359,IEPA.d109,True,"Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control",IEPA.d109.s261,leptin,UCP-2
360,IEPA.d109,False,"Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control",IEPA.d109.s261,leptin,UCP-2
361,IEPA.d109,False,"Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control",IEPA.d109.s261,leptin,leptin
362,IEPA.d109,False,"Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control",IEPA.d109.s261,leptin,UCP-2
363,IEPA.d109,False,"Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control",IEPA.d109.s261,UCP-2,leptin
364,IEPA.d109,False,"Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control",IEPA.d109.s261,UCP-2,UCP-2
365,IEPA.d109,False,"Fasting significantly enhanced gastrocnemius muscle UCP-3 mRNA (411% of control) and protein expression (168% of control), whereas leptin administration to fasted rats did not alter either of these effects",IEPA.d109.s262,UCP-3,leptin
366,IEPA.d109,True,"In summary, UCP subtype mRNA and protein are regulated in tissue- and subtype-specific fashion by leptin and food restriction",IEPA.d109.s263,UCP,leptin
367,IEPA.d111,False,"Plasma oxytocin, and some functionally related peptides (CCK, gastrin, somatostatin and insulin), were measured by standard radioimmunoassay techniques",IEPA.d111.s269,oxytocin,insulin
368,IEPA.d112,True,"Analyses of hormone regulation of expression of mRNA for the aleurone RNase revealed that, like the pattern for alpha-amylase, mRNA levels increased in the presence of gibberellic acid, and its antagonist abscisic acid prevented this effect",IEPA.d112.s270,alpha-amylase,gibberellic acid
369,IEPA.d112,True,"Quantitative studies at early times demonstrated that cycloheximide treatment of aleurone layers increased mRNA levels 4-fold, whereas a combination of gibberellin plus cycloheximide treatment was required to increase alpha-amylase mRNA levels to the same extent",IEPA.d112.s271,gibberellin,alpha-amylase
370,IEPA.d113,False,"The experiments were concluded by taking blood samples for later analysis of plasma glucose and plasma levels of the following hormones: insulin, gastrin, CCK, glucagon, somatostatin, oxytocin and corticosterone",IEPA.d113.s272,insulin,oxytocin
371,IEPA.d113,False,"The low-performing Stock B animals were characterized by [1] being more reactive to sensory stimulation: higher startle amplitude and shorter startle latency; [2] having higher plasma insulin and corticosterone levels, whereas plasma gastrin and oxytocin were significantly lowered and a strong tendency for a decrease also in plasma CCK",IEPA.d113.s273,insulin,oxytocin
372,IEPA.d114,True,"In normal pancreatic islets, UCP-2 is upregulated by leptin and is low in leptin-resistant islets of ZDF rats",IEPA.d114.s274,UCP-2,leptin
373,IEPA.d114,False,"In normal pancreatic islets, UCP-2 is upregulated by leptin and is low in leptin-resistant islets of ZDF rats",IEPA.d114.s274,UCP-2,leptin
374,IEPA.d114,False,"In normal pancreatic islets, UCP-2 is upregulated by leptin and is low in leptin-resistant islets of ZDF rats",IEPA.d114.s274,leptin,leptin
375,IEPA.d114,False,"To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275,UCP-2,leptin
376,IEPA.d114,False,"To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275,UCP-2,UCP-2
377,IEPA.d114,False,"To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275,UCP-2,UCP-2
378,IEPA.d114,False,"To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275,leptin,UCP-2
379,IEPA.d114,False,"To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275,leptin,UCP-2
380,IEPA.d114,False,"To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats",IEPA.d114.s275,UCP-2,UCP-2
381,IEPA.d114,False,"We conclude that UCP-2 has uncoupling function when overexpressed in leptin-insensitive islets and that its overexpression corrects the underexpression of the insulin gene and ameliorates glucose-stimulated insulin secretion, possibly by increasing the ATP:ADP ratio",IEPA.d114.s276,UCP-2,leptin
382,IEPA.d117,True,"The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone",IEPA.d117.s285,GA3,alpha-amylase
383,IEPA.d117,False,"The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone",IEPA.d117.s285,GA,GA
384,IEPA.d117,False,"The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone",IEPA.d117.s285,GA,GA3
385,IEPA.d117,False,"The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone",IEPA.d117.s285,GA,alpha-amylase
386,IEPA.d117,False,"The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone",IEPA.d117.s285,GA,GA3
387,IEPA.d117,False,"The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone",IEPA.d117.s285,GA,alpha-amylase
388,IEPA.d118,False,"Phorbol myristate acetate (TPA), an activator of PKC, elicited an increase of MAPK activity, but did not further influence the level of AVP4-8-enhanced MAPK activity; Nevertheless, the extent of CaMKII activation was attenuated by TPA",IEPA.d118.s286,PKC,AVP
389,IEPA.d119,True,The gibberellin-responsive elements conserved in cereal alpha-amylase genes are not included in the 5'-upstream region of Rep1 or RepA,IEPA.d119.s287,gibberellin,alpha-amylase
390,IEPA.d120,True,"Furthermore, our 14C-acetate-labeling studies showed a 50% reduction in cholesteryl ester synthesis in the presence of either flavonoid, which could account for the reduction in net apoB secretion caused by incubation with these compounds",IEPA.d120.s288,cholesteryl ester,flavonoid
391,IEPA.d121,False,"An inhibitor of PKC, Ro31-8220 (10 microM), abolished the ability of PDBu to decrease [Ca(2+)](i), without affecting the response to maximal or submaximal concentrations of AVP",IEPA.d121.s289,PKC,AVP
392,IEPA.d122,True,Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue,IEPA.d122.s290,leptin,uncoupling proteins
393,IEPA.d122,True,Centrally administered leptin has been shown to increase insulin-stimulated glucose utilization and to favor the expression of uncoupling proteins (UCPs),IEPA.d122.s291,leptin,uncoupling proteins
394,IEPA.d122,False,"To study if leptin also has direct peripherally mediated effects on these processes, this hormone (1 mg/day) or its vehicle was infused i.v. for 4 days to lean rats and insulin-stimulated glucose utilization in skeletal muscle and adipose tissue as well as the expression of UCP messenger RNAs (mRNAs) in brown adipose tissue were measured",IEPA.d122.s292,leptin,UCP
395,IEPA.d122,True,"I.v. leptin infusion also favored the expression of UCPs in brown adipose tissue, either by increasing their expression or preventing the fall occurring during the pair-feeding regimen.",IEPA.d122.s293,leptin,UCPs
396,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP,UCP1
397,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP,UCP2
398,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP,UCP3
399,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP,leptin
400,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP1,UCP2
401,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP1,UCP3
402,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP1,leptin
403,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP2,UCP3
404,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP2,leptin
405,IEPA.d122,False,"Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively",IEPA.d122.s294,UCP3,leptin
406,IEPA.d122,True,These results suggest that the overall effect of leptin on glucose utilization and on the expression of UCPs may be mediated through central mechanism,IEPA.d122.s295,leptin,UCPs
407,IEPA.d126,True,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,leptin,UCP2
408,IEPA.d126,True,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,leptin,UCP3
409,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP2,UCP3
410,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP2,leptin
411,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP2,leptin
412,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP2,UCP2
413,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP2,UCP3
414,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP3,leptin
415,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP3,leptin
416,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP3,UCP2
417,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP3,UCP3
418,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,leptin,leptin
419,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,leptin,UCP2
420,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,leptin,UCP3
421,IEPA.d126,False,"The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels",IEPA.d126.s299,UCP2,UCP3
422,IEPA.d126,True,"These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels",IEPA.d126.s300,UCP2,leptin
423,IEPA.d126,True,"These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels",IEPA.d126.s300,UCP3,leptin
424,IEPA.d126,False,"These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels",IEPA.d126.s300,UCP,UCP2
425,IEPA.d126,False,"These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels",IEPA.d126.s300,UCP,UCP3
426,IEPA.d126,False,"These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels",IEPA.d126.s300,UCP,leptin
427,IEPA.d126,False,"These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels",IEPA.d126.s300,UCP2,UCP3
428,IEPA.d127,True,PI-PLC treatment of fetal guinea pig brain cultures substantially reduced the amount of Abeta40 and Abeta42 in the medium but had no effect on sAPPalpha,IEPA.d127.s301,PI-PLC,Abeta40
429,IEPA.d127,True,PI-PLC treatment of fetal guinea pig brain cultures substantially reduced the amount of Abeta40 and Abeta42 in the medium but had no effect on sAPPalpha,IEPA.d127.s301,PI-PLC,Abeta42
430,IEPA.d127,False,PI-PLC treatment of fetal guinea pig brain cultures substantially reduced the amount of Abeta40 and Abeta42 in the medium but had no effect on sAPPalpha,IEPA.d127.s301,Abeta40,Abeta42
431,IEPA.d127,True,"When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC",IEPA.d127.s302,PI-PLC,Abeta40
432,IEPA.d127,True,"When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC",IEPA.d127.s302,PI-PLC,Abeta42
433,IEPA.d127,False,"When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC",IEPA.d127.s302,PI-PLC,PI-PLC
434,IEPA.d127,False,"When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC",IEPA.d127.s302,Abeta40,Abeta42
435,IEPA.d127,False,"When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC",IEPA.d127.s302,Abeta40,PI-PLC
436,IEPA.d127,False,"When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC",IEPA.d127.s302,Abeta42,PI-PLC
437,IEPA.d128,True,"A neurotoxic fragment of amyloid, Abeta 25-35, incubated in the presence of endogenous Ca2+, increased significantly the PI-PLC activity of normoxic brain",IEPA.d128.s303,amyloid,PI-PLC
438,IEPA.d128,True,"In its non-aggregated form, Abeta 25-35 activates PI-PLC but in the aggregated form the enzymatic activity decreased",IEPA.d128.s304,Abeta 25-35,PI-PLC
439,IEPA.d128,True,"Thus, Abeta 25-35 exerts a similar effect on the membrane-bound PI-PLC from normoxic brain or subjected to ischemia reperfusion injury",IEPA.d128.s305,Abeta 25-35,PI-PLC
440,IEPA.d128,True,Ischemia-reperfusion injury had no effect on Abeta-evoked alterations of synaptic plasma membrane-bound PI-PLC,IEPA.d128.s306,Abeta,PI-PLC
441,IEPA.d129,False,"Sympathetic inhibition, leptin, and uncoupling protein subtype expression in normal fasting rats",IEPA.d129.s307,leptin,uncoupling protein
442,IEPA.d129,False,"To further investigate neural effects on leptin and uncoupling proteins (UCPs), we studied in vivo perturbations intended to block adrenergic input to peripheral tissues",IEPA.d129.s308,leptin,uncoupling proteins
443,IEPA.d129,False,"We examined plasma leptin, leptin mRNA, and adipose and muscle UCP subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system",IEPA.d129.s309,leptin,leptin
444,IEPA.d129,False,"We examined plasma leptin, leptin mRNA, and adipose and muscle UCP subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system",IEPA.d129.s309,leptin,UCP
445,IEPA.d129,False,"We examined plasma leptin, leptin mRNA, and adipose and muscle UCP subtype mRNA in rats treated with alpha-methyl-p-tyrosine methyl ester (AMPT-ME), which inhibits catecholamine synthesis and 6-hydroxydopamine (6HDA), which is toxic to catecholinergic nerve terminals but, unlike AMPT-ME, does not enter the central nervous system",IEPA.d129.s309,leptin,UCP
446,IEPA.d129,False,"Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma leptin approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) leptin mRNA by two- to threefold, and decreased IBAT UCP-3 mRNA to 30-40% of control",IEPA.d129.s310,leptin,leptin
447,IEPA.d129,False,"Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma leptin approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) leptin mRNA by two- to threefold, and decreased IBAT UCP-3 mRNA to 30-40% of control",IEPA.d129.s310,leptin,UCP-3
448,IEPA.d129,False,"Intraperitoneal 6HDA, 100 mg/kg, as a single dose at 1800, increased plasma leptin approximately twofold after 18-20 h, increased IBAT (but not epididymal fat) leptin mRNA by two- to threefold, and decreased IBAT UCP-3 mRNA to 30-40% of control",IEPA.d129.s310,leptin,UCP-3
449,IEPA.d129,False,"However, the in vivo modulation of leptin and UCPs appears complex and, beyond a causal effect of SNA per se, may depend on concurrent changes in plasma insulin, glucose, and circulatory hemodynamics",IEPA.d129.s311,leptin,UCPs
450,IEPA.d130,True,Amyloid beta peptide 25-35 modulates hydrolysis of phosphoinositides by membrane phospholipase(s) C of adult brain cortex,IEPA.d130.s312,Amyloid,phospholipase(s) C
451,IEPA.d130,True,"Fresh-water-soluble A beta 25-35 activated PI-PLC in SPM markedly by two- to threefold, but this effect was absent in the presence of 2 mM CaCl2",IEPA.d130.s313,A beta,PI-PLC
452,IEPA.d130,False,"Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC",IEPA.d130.s314,A beta,PIP2-PLC
453,IEPA.d130,False,"Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC",IEPA.d130.s314,A beta,PI-PLC
454,IEPA.d130,False,"Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC",IEPA.d130.s314,A beta,PIP2-PLC
455,IEPA.d130,False,"Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC",IEPA.d130.s314,PIP2-PLC,PI-PLC
456,IEPA.d130,False,"Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC",IEPA.d130.s314,PIP2-PLC,PIP2-PLC
457,IEPA.d130,False,"Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC",IEPA.d130.s314,PI-PLC,PIP2-PLC
458,IEPA.d130,True,The aggregated form of A beta 25-35 significantly inhibited PIP2-PLC only in the presence of endogenous CaCl2,IEPA.d130.s315,A beta,PIP2-PLC
459,IEPA.d131,True,"Vasopressin stimulates tyrosine phosphorylation by activation of PKC in the rat smooth muscle cell line, A-10",IEPA.d131.s316,Vasopressin,PKC
460,IEPA.d131,True,"The protein kinase C (PKC) inhibitors: staurosporine, H7 and GF109203X are able to block the AVP-stimulated phosphorylation",IEPA.d131.s317,protein kinase C,AVP
461,IEPA.d131,True,"These results indicate that PKC is upstream of the phosphorylation, a motion which is supported by the fact that the AVP-stimulated phosphorylation was downregulated by phorbol esters",IEPA.d131.s318,PKC,AVP
462,IEPA.d132,True,The effects of the fluorinated analogues were evaluated on inhibition of cress seed germination and inhibition of gibberellin-inducible alpha-amylase induction in embryoless barley half-seeds,IEPA.d132.s319,gibberellin,alpha-amylase
463,IEPA.d132,True,"(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production",IEPA.d132.s320,gibberellin,alpha-amylase
464,IEPA.d132,False,"(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production",IEPA.d132.s320,gibberellin,alpha-amylase
465,IEPA.d132,False,"(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production",IEPA.d132.s320,alpha-amylase,alpha-amylase
466,IEPA.d133,False,"Neurotransmitters and hormones, such as arginine vasopressin (AVP) and bombesin, evoke frequency-modulated repetitive Ca2+ transients in insulin-secreting HIT-T15 cells by binding to receptors linked to phospholipase C (PLC)",IEPA.d133.s321,insulin,phospholipase C
467,IEPA.d134,True,"Isolation and characterization of gibbestatin B, an inhibitor of gibberellin-induced expression of alpha-amylase, and gibbestatin C from streptomycetaes",IEPA.d134.s322,gibberellin,alpha-amylase
468,IEPA.d137,True,We previously showed that arginine vasopressin (AVP) stimulates heat shock protein 27 (HSP27) induction through protein kinase C activation in aortic smooth muscle A10 cells,IEPA.d137.s325,arginine vasopressin,protein kinase C
469,IEPA.d137,True,"Calphostin C and ET-18-OCH(3), inhibitors of protein kinase C, reduced the phosphorylation of p38 MAP kinase by AVP",IEPA.d137.s326,protein kinase C,AVP
470,IEPA.d138,False,"Insulin-like signaling in yeast: modulation of protein phosphatase 2A, protein kinase A, cAMP-specific phosphodiesterase, and glycosyl-phosphatidylinositol-specific phospholipase C activities",IEPA.d138.s327,Insulin,phospholipase C
471,IEPA.d138,True,"In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC",IEPA.d138.s328,glycosyl-phosphatidylinositol-specific phospholipase C,insulin
472,IEPA.d138,True,"In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC",IEPA.d138.s328,glycosyl-phosphatidylinositol-specific phospholipase C,insulin
473,IEPA.d138,False,"In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC",IEPA.d138.s328,glycosyl-phosphatidylinositol-specific phospholipase C,GPI-PLC
474,IEPA.d138,False,"In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC",IEPA.d138.s328,insulin,insulin
475,IEPA.d138,False,"In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC",IEPA.d138.s328,insulin,GPI-PLC
476,IEPA.d138,False,"In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC",IEPA.d138.s328,insulin,GPI-PLC
477,IEPA.d138,True,GPI-PLC was most pronouncedly stimulated by authentic human insulin compared to various insulin analogues and insulin-like growth factor I,IEPA.d138.s329,GPI-PLC,insulin
478,IEPA.d138,False,"As the GPI-PLC reaction is rate limiting, the efficiency of the two-step anchor cleavage was significantly increased when insulin was present together with glucose as compared to glucose alone",IEPA.d138.s330,GPI-PLC,insulin
479,IEPA.d138,True,"The insulin concentrations effective in modulating PP2A, PKA, cAMP-PDE, and GPI-PLC activities correlate well with those required for half-saturation of the specific binding sites as well as for stimulation of protein phosphorylation and glycogen accumulation",IEPA.d138.s331,insulin,GPI-PLC
480,IEPA.d138,True,"The data suggest that mammalian insulin-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and GPI-PLC) involved in the transduction of the insulin signal from the respective receptor systems to glycogen synthase and phosphorylase",IEPA.d138.s332,GPI-PLC,insulin
481,IEPA.d138,False,"The data suggest that mammalian insulin-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and GPI-PLC) involved in the transduction of the insulin signal from the respective receptor systems to glycogen synthase and phosphorylase",IEPA.d138.s332,insulin,GPI-PLC
482,IEPA.d138,False,"The data suggest that mammalian insulin-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and GPI-PLC) involved in the transduction of the insulin signal from the respective receptor systems to glycogen synthase and phosphorylase",IEPA.d138.s332,insulin,insulin
483,IEPA.d139,False,Leptin and UCP (1 and 2) mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) methodology in adipose tissue and gastrocnemius muscle,IEPA.d139.s333,Leptin,UCP
484,IEPA.d139,False,"A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression",IEPA.d139.s334,UCP2,UCP2
485,IEPA.d139,False,"A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression",IEPA.d139.s334,UCP2,leptin
486,IEPA.d139,False,"A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression",IEPA.d139.s334,UCP2,leptin
487,IEPA.d139,False,"A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression",IEPA.d139.s334,UCP2,leptin
488,IEPA.d139,False,"A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression",IEPA.d139.s334,UCP2,leptin
489,IEPA.d139,False,"A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression",IEPA.d139.s334,leptin,leptin
490,IEPA.d140,True,Arginine vasopressin (AVP) and lysophosphatidic acid (LPA) have been shown to stimulate protein kinase C (PKC) and mitogen-activated protein (MAP) kinases and the proliferation of vascular smooth muscle cells,IEPA.d140.s335,Arginine vasopressin,protein kinase C
491,IEPA.d140,True,"However, AVP-induced activation of RSK2, a downstream substrate of ERK1 and ERK2, was PKC-dependent and PI 3-kinase-independent",IEPA.d140.s336,AVP,PKC
492,IEPA.d140,True,PKC was necessary in AVP- but not in LPA-induced activation of p70 S6K,IEPA.d140.s337,PKC,AVP
493,IEPA.d141,True,Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells,IEPA.d141.s338,phospholipase C,insulin
494,IEPA.d141,True,"We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked insulin secretion from HIT-T15 cells",IEPA.d141.s339,PLC,insulin
495,IEPA.d141,False,"We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked insulin secretion from HIT-T15 cells",IEPA.d141.s339,PLC,PLC
496,IEPA.d141,False,"We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked insulin secretion from HIT-T15 cells",IEPA.d141.s339,PLC,insulin
497,IEPA.d141,True,"Thus tolbutamide and diazoxide regulate both PLC-linked Ca(2+) signaling and insulin secretion from pancreatic beta-cells by modulating K(ATP) channels, thereby determining voltage-sensitive Ca(2+) influx",IEPA.d141.s340,PLC,insulin
498,IEPA.d143,True,Oxytocin central injections to intact animals stimulated insulin synthesis and secretion without changing of islets area,IEPA.d143.s343,Oxytocin,insulin
499,IEPA.d143,True,"Thus, oxytocin administration stimulates insulin synthesis and secretion in intact and diabetic animals and this effect is more expressed with central injections",IEPA.d143.s344,oxytocin,insulin
500,IEPA.d144,True,Hypothalamic neuropeptide Y and its neuroendocrine regulation by leptin,IEPA.d144.s345,neuropeptide Y,leptin
501,IEPA.d146,True,Ca2+ signalling in rat vascular smooth muscle cells: a role for protein kinase C at physiological vasoconstrictor concentrations of vasopressin,IEPA.d146.s351,protein kinase C,vasopressin
502,IEPA.d146,False,"The protein kinase C (PKC) activator 4beta-phorbol 12-myristate 13-acetate (PMA, 100 pM to 200 nM), also stimulated Ca2+ spiking and this effect was additive with a submaximal concentration of AVP (50 pM)",IEPA.d146.s352,protein kinase C,AVP
503,IEPA.d146,True,The PKC inhibitors Ro-31-8220 (1 microM) and calphostin C (250 nM) completely blocked the stimulation of Ca2+ spiking by either PMA or AVP,IEPA.d146.s353,PKC inhibitors,AVP
504,IEPA.d146,True,"Time-dependent redistribution of PKC-alpha, -delta and -epsilon isoforms between the membrane and cytosolic fractions occurred in response to 100 pM AVP",IEPA.d146.s354,PKC-alpha,AVP
505,IEPA.d146,False,"Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP",IEPA.d146.s355,PKC-alpha,PKC-epsilon
506,IEPA.d146,False,"Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP",IEPA.d146.s355,PKC-alpha,AVP
507,IEPA.d146,False,"Pretreatment for 24 h with 1 microM PMA downregulated expression of PKC-alpha and -delta, but not PKC-epsilon, and prevented the Ca2+-spiking responses to either 1 nM PMA or 100 pM AVP",IEPA.d146.s355,PKC-epsilon,AVP
508,IEPA.d146,True,We conclude that PKC activation is a necessary step in the signal transduction pathway linking low concentrations of AVP to Ca2+ spiking in A7r5 cells,IEPA.d146.s356,PKC,AVP
509,IEPA.d147,False,Ten protein kinases have been assayed for their ability to phosphorylate in vitro the recombinant bovine PrP (25-242) (rbPrP),IEPA.d147.s357,protein kinases,recombinant bovine PrP
510,IEPA.d147,True,"With regard to CK2, phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol rbPrP, which is doubled by mild heat treatment of rbPrP",IEPA.d147.s358,CK2,rbPrP
511,IEPA.d147,False,"With regard to CK2, phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol rbPrP, which is doubled by mild heat treatment of rbPrP",IEPA.d147.s358,CK2,rbPrP
512,IEPA.d147,False,"With regard to CK2, phosphorylation occurs at Ser 154 with a stoichiometry of about 0.1 mol phosphate/mol rbPrP, which is doubled by mild heat treatment of rbPrP",IEPA.d147.s358,rbPrP,rbPrP
513,IEPA.d148,False,In vivo effects of CGP-12177 on the expression of leptin and uncoupling protein genes in mouse brown and white adipose tissues,IEPA.d148.s359,leptin,uncoupling protein
514,IEPA.d148,False,"OBJECTIVE: To assess the effect of chronic treatment with CGP-12177 a beta3-adrenergic receptor (AR) agonist with beta2/beta1-AR antagonist action, on the expression of the leptin gene and of genes coding for uncoupling proteins (ucp1, ucp2 and ucp3) in brown and white adipose tissues",IEPA.d148.s360,leptin,uncoupling proteins
515,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361,ucp,leptin
516,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361,ucp,leptin
517,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361,ucp,ucp
518,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361,leptin,leptin
519,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361,leptin,ucp
520,IEPA.d148,False,"CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways",IEPA.d148.s361,leptin,ucp
521,IEPA.d149,True,"Furthermore, in SN-56/OBR cells both CNTF and leptin produce changes in neurotransmitter and neuropeptide phenotype characteristic of cholinergic neurons, such as an increase in choline acetyltransferase and vasoactive intestinal polypeptide, and a decrease in neuropeptide Y expression",IEPA.d149.s362,leptin,neuropeptide Y
522,IEPA.d150,True,Possible central nervous system (CNS) mechanisms could mediate these responses in that leptin receptors are located on hypothalamic neurons that coexpress neuropeptide-Y (NPY) or proopiomelanocortin (POMC) and both peptides that have been implicated as mediators of the CNS action of leptin.,IEPA.d150.s363,neuropeptide-Y,leptin
523,IEPA.d150,True,Leptin has been demonstrated to decrease or down regulate NPY expression and increase POMC expression,IEPA.d150.s364,Leptin,NPY
524,IEPA.d151,True,"Relationship among leptin, neuropeptide Y, and galanin in young women and in postmenopausal women [see comments]",IEPA.d151.s365,leptin,neuropeptide Y
525,IEPA.d151,False,"OBJECTIVE: To determine whether hormonal status may affect neuropeptide Y (NPY), galanin, and leptin release in postmenopausal women and in young women",IEPA.d151.s366,neuropeptide Y,leptin
526,IEPA.d151,False,"CONCLUSIONS: Our results suggest that the differences is plasma leptin, NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved",IEPA.d151.s367,leptin,NPY
527,IEPA.d151,False,"CONCLUSIONS: Our results suggest that the differences is plasma leptin, NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved",IEPA.d151.s367,leptin,NPY
528,IEPA.d151,False,"CONCLUSIONS: Our results suggest that the differences is plasma leptin, NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved",IEPA.d151.s367,NPY,NPY
529,IEPA.d152,False,"We examined for the first time in young men effects of intravenous injections of NPY (4x50 or 100 microg, n = 9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and leptin",IEPA.d152.s368,NPY,leptin
530,IEPA.d153,True,"Interestingly, both 5-HT and leptin modulate the action of NPY, which may form a part of a common output pathway for the expression of appetite",IEPA.d153.s369,leptin,NPY
531,IEPA.d154,True,"The glycosyl-phosphatidylinositol anchored protein, membrane dipeptidase (EC 3.4.13.19) is released from the surface of 3T3-L1 adipocytes in response to insulin treatment through the action of a phospholipase C",IEPA.d154.s370,insulin,phospholipase C
532,IEPA.d154,False,"Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release",IEPA.d154.s371,phospholipase C,insulin
533,IEPA.d154,False,"Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release",IEPA.d154.s371,phospholipase C,insulin
534,IEPA.d154,False,"Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release",IEPA.d154.s371,insulin,insulin
535,IEPA.d155,False,"However, neither progesterone nor insulin increased phosphotyrosine on PLCgamma",IEPA.d155.s372,insulin,PLCgamma
536,IEPA.d156,True,"Leptin is a satiety factor which acts within the hypothalamus to decrease the levels of several neuropeptides stimulating food intake (among them, neuropeptide Y [NPY]), while increasing those that inhibit food intake",IEPA.d156.s373,Leptin,neuropeptide Y
537,IEPA.d157,True,"We have studied the effects of neomycin, a potent inhibitor of inositol phospholipid-specific phospholipase C (PLC), on the germination of rice seed and the gibberellin-induced expression of alpha-amylase in the aleurone layer and the scutellar tissues",IEPA.d157.s374,gibberellin,alpha-amylase
538,IEPA.d157,True,"It was shown that, in the absence of exogenous Ca2+, neomycin markedly reduced the germination speed and seedling growth of rice seeds and inhibited the gibberellin-induced expression of alpha-amylase in both secretory tissues",IEPA.d157.s375,gibberellin,alpha-amylase
539,IEPA.d157,True,These results strongly suggest that the phosphoinositide-Ca2+ signal transduction pathway may play an important role in the gibberellin-induced expression of alpha-amylase molecules closely related to the germination processes of rice seed,IEPA.d157.s376,gibberellin,alpha-amylase
540,IEPA.d158,False,NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior,IEPA.d158.s377,NPY,leptin
541,IEPA.d158,False,Many studies have indicated that neuropeptide Y (NPY) stimulates and leptin inhibits food intake,IEPA.d158.s378,neuropeptide Y,leptin
542,IEPA.d158,False,"In line with this, intracerebroventricular injection of NPY (10 microg) stimulated and leptin (10 microg) inhibited intake of a sucrose solution when female rats were required to obtain the solution from a bottle",IEPA.d158.s379,NPY,leptin
543,IEPA.d158,False,"However, NPY inhibited and leptin stimulated intake if the solution was infused intraorally",IEPA.d158.s380,NPY,leptin
544,IEPA.d158,False,"Thus NPY stimulates the responses used to obtain food but inhibits those used to consume food, and leptin has the opposite effects",IEPA.d158.s381,NPY,leptin
545,IEPA.d159,True,"In the fasting state UCP-2 expression correlated inversely with body mass index (r = -0.45; P = 0.026), percent body fat (r = -0.41; P = 0.05), plasma insulin (r = -0.47; P = 0.02), epigastric venous fatty acids (r = -0.45; P = 0.04), and leptin (r = -0.50; P = 0.018)",IEPA.d159.s382,UCP-2,leptin
546,IEPA.d159,True,UCP-2 expression remained inversely related with plasma leptin after controlling for percent body (r = -0.45; P = 0.038),IEPA.d159.s383,UCP-2,leptin
547,IEPA.d159,True,"In conclusion, 1) UCP-2 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma leptin levels; and 2) UCP-2 expression is not acutely regulated by food intake, insulin, or fatty acids",IEPA.d159.s384,UCP-2,leptin
548,IEPA.d159,False,"In conclusion, 1) UCP-2 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma leptin levels; and 2) UCP-2 expression is not acutely regulated by food intake, insulin, or fatty acids",IEPA.d159.s384,UCP-2,UCP-2
549,IEPA.d159,False,"In conclusion, 1) UCP-2 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma leptin levels; and 2) UCP-2 expression is not acutely regulated by food intake, insulin, or fatty acids",IEPA.d159.s384,leptin,UCP-2
550,IEPA.d160,False,"Thus, highly expressed in human adipocytes, the Y(1) receptor sustains the strong antilipolytic effect of NPY and exerts a positive action on leptin secretion",IEPA.d160.s385,NPY,leptin
551,IEPA.d161,False,"Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion",IEPA.d161.s386,leptin,uncoupling proteins 2
552,IEPA.d161,False,"Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion",IEPA.d161.s386,leptin,3
553,IEPA.d161,False,"Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion",IEPA.d161.s386,uncoupling proteins 2,3
554,IEPA.d161,False,"Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia",IEPA.d161.s387,leptin,uncoupling protein (UCP)-2
555,IEPA.d161,False,"Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia",IEPA.d161.s387,leptin,UCP-3
556,IEPA.d161,False,"Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia",IEPA.d161.s387,uncoupling protein (UCP)-2,UCP-3
557,IEPA.d161,False,"Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion",IEPA.d161.s388,leptin,UCP-2
558,IEPA.d161,False,"Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion",IEPA.d161.s388,leptin,UCP-3
559,IEPA.d161,False,"Marked increases in FAT/CD36 (724+/-18%; P < 0.05), PPAR-gamma2 (200+/-8%; P < 0.05), leptin (110+/-13%; P < 0.05), UCP-2 (120+/-7%; P < 0.05), UCP-3 (80+/-5%; P < 0.05), and TNF-alpha mRNA (130+/-12%; P < 0.05) were observed in comparison with pretreatment levels, whereas there was no change after saline infusion",IEPA.d161.s388,UCP-2,UCP-3
560,IEPA.d161,False,"These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins",IEPA.d161.s389,leptin,UCP-2
561,IEPA.d161,False,"These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins",IEPA.d161.s389,leptin,UCP-3
562,IEPA.d161,False,"These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins",IEPA.d161.s389,UCP-2,UCP-3
563,IEPA.d162,False,"We previously reported that adiposity and serum leptin levels increase with age in male F-344xBN rats and that when physiological levels of serum leptin are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic neuropeptide Y (NPY) mRNA in young rats, but there are no changes in older rats",IEPA.d162.s390,leptin,leptin
564,IEPA.d162,False,"We previously reported that adiposity and serum leptin levels increase with age in male F-344xBN rats and that when physiological levels of serum leptin are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic neuropeptide Y (NPY) mRNA in young rats, but there are no changes in older rats",IEPA.d162.s390,leptin,neuropeptide Y
565,IEPA.d162,False,"We previously reported that adiposity and serum leptin levels increase with age in male F-344xBN rats and that when physiological levels of serum leptin are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic neuropeptide Y (NPY) mRNA in young rats, but there are no changes in older rats",IEPA.d162.s390,leptin,neuropeptide Y
566,IEPA.d162,True,These findings suggest that the regulation of hypothalamic NPY mRNA by leptin may be impaired with age,IEPA.d162.s391,NPY,leptin
567,IEPA.d162,False,"We examined daily food consumption, body weight, whole-body oxygen consumption, serum leptin, and NPY mRNA in the hypothalamus",IEPA.d162.s392,leptin,NPY
568,IEPA.d162,True,"Leptin infusion diminished hypothalamic NPY levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats",IEPA.d162.s393,Leptin,NPY
569,IEPA.d162,False,"Leptin infusion diminished hypothalamic NPY levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats",IEPA.d162.s393,Leptin,NPY
570,IEPA.d162,False,"Leptin infusion diminished hypothalamic NPY levels by nearly 50% compared with pair-fed young rats, whereas there were no changes in the hypothalamic NPY mRNA levels in senescent rats",IEPA.d162.s393,NPY,NPY
571,IEPA.d162,False,These diminished responses to leptin were associated with and may be the result of an impaired suppression of hypothalamic NPY mRNA levels,IEPA.d162.s394,leptin,NPY
572,IEPA.d163,False,C75 inhibited expression of the prophagic signal neuropeptide Y in the hypothalamus and acted in a leptin-independent manner that appears to be mediated by malonyl-coenzyme A,IEPA.d163.s395,neuropeptide Y,leptin
573,IEPA.d164,False,"The aims of this study were: (1) to assess the effects of maternal undernutrition during pregnancy on adult offspring with regard to growth, body composition and plasma levels of glucose, insulin and corticosterone, and (2) to investigate whether oxytocin treatment early in life could ameliorate the adverse effects of food restriction in utero",IEPA.d164.s396,insulin,oxytocin
574,IEPA.d165,True,Interactions between leptin and NPY affecting lipid mobilization in adipose tissue,IEPA.d165.s397,leptin,NPY
575,IEPA.d165,False,The aim of the current investigations was focused on the study of the involvement of leptin and neuropeptide Y in lipid mobilization,IEPA.d165.s398,leptin,neuropeptide Y
576,IEPA.d165,False,The lipolytic rate was assessed through glycerol release after incubation with leptin and NPY at concentrations ranging from 10(-6) to 10(-12) M in isolated adipocytes obtained from female rats,IEPA.d165.s399,leptin,NPY
577,IEPA.d165,False,"At equimolar concentrations of leptin and NPY (10(-12) to 10(-6) M) the observed lipolytic activity is comparable to the basal lipolytic activity, except at a concentration of 10(-9) M where upon a significant increase in lipolysis is observed",IEPA.d165.s400,leptin,NPY
578,IEPA.d165,True,"Summing up, new evidence suggests that NPY and leptin may interact in a homeostatic loop to regulate body-fat mass and energy balance not only at the central nervous system level, but also directly at the adipocyte level",IEPA.d165.s401,NPY,leptin
579,IEPA.d166,False,The protein kinase C specific inhibitor Go-6983 further enhanced the inhibitory effect of VACM-1 on AVP-stimulated cAMP production,IEPA.d166.s402,protein kinase C,AVP
580,IEPA.d168,True,Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle,IEPA.d168.s404,leptin,uncoupling protein-3
581,IEPA.d168,True,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3",IEPA.d168.s405,leptin,uncoupling protein-3
582,IEPA.d168,True,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3",IEPA.d168.s405,leptin,UCP-3
583,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3",IEPA.d168.s405,leptin,leptin
584,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3",IEPA.d168.s405,leptin,UCP-3
585,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3",IEPA.d168.s405,uncoupling protein-3,leptin
586,IEPA.d168,False,"A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3",IEPA.d168.s405,uncoupling protein-3,UCP-3
587,IEPA.d168,True,"To further substantiate an involvement of thyroid hormones in the effect of leptin on muscle UCP-3 expression, hypothyroid rats were ICV infused with leptin or vehicle",IEPA.d168.s406,leptin,UCP-3
588,IEPA.d168,False,"To further substantiate an involvement of thyroid hormones in the effect of leptin on muscle UCP-3 expression, hypothyroid rats were ICV infused with leptin or vehicle",IEPA.d168.s406,leptin,leptin
589,IEPA.d168,False,"To further substantiate an involvement of thyroid hormones in the effect of leptin on muscle UCP-3 expression, hypothyroid rats were ICV infused with leptin or vehicle",IEPA.d168.s406,UCP-3,leptin
590,IEPA.d168,True,"It was observed that in hypothyroid rats, ICV leptin was unable to maintain muscle UCP-3 expression at values measured in ad libitum fed controls",IEPA.d168.s407,leptin,UCP-3
591,IEPA.d168,True,"These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle UCP-3 expression",IEPA.d168.s408,leptin,UCP-3
592,IEPA.d168,False,"These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle UCP-3 expression",IEPA.d168.s408,leptin,leptin
593,IEPA.d168,False,"These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle UCP-3 expression",IEPA.d168.s408,leptin,UCP-3
594,IEPA.d169,False,"The body mass index (BMI), leptin, plasma neuropeptide Y (NPY), serotonin, thyroxine (T4), triiodothyronine (T3) and reverse triiodothyronine (rT3) in serum were evaluated for each subject",IEPA.d169.s409,leptin,neuropeptide Y
595,IEPA.d171,False,"Phospholipase C (PLC) activity was investigated by stimulation of membrane preparations obtained from insulin (beta-TC3)-, somatostatin (Rin 1027-B2)-, and glucagon (INR1-G9)-producing pancreatic cell lines using the non-hydrolyzable GTP analogue GTPgammaS alone, the C-terminal octapeptide cholecystokinin (CCK-8), or gastrin",IEPA.d171.s415,Phospholipase C,insulin
596,IEPA.d172,True,"Therefore, it was examined whether stimulation of Swiss 3T3 cells with insulin causes changes in the subcellular distribution of EGF receptors and phospholipase Cgamma1 that could potentially explain the observed synergy or costimulation.",IEPA.d172.s416,insulin,phospholipase Cgamma1
597,IEPA.d172,True,"However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.",IEPA.d172.s417,insulin,phospholipase Cgamma1
598,IEPA.d172,False,"However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.",IEPA.d172.s417,insulin,insulin
599,IEPA.d172,False,"However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells.",IEPA.d172.s417,phospholipase Cgamma1,insulin
600,IEPA.d172,True,"Therefore, it is suggested that the insulin-induced coclustering of the EGF receptor with phospholipase Cgamma1 at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.",IEPA.d172.s418,insulin,phospholipase Cgamma1
601,IEPA.d173,False,We have established that the recovery of secreted N1 is increased by the protein kinase C agonists PDBu and PMA in a time- and dose-dependent manner in both cell lines,IEPA.d173.s419,N1,protein kinase C
602,IEPA.d173,False,"In contrast, secretion of N1 remains unaffected by the inactive PDBu analog alphaPDD and by the protein kinase A effectors dibutyryl cAMP and forskolin",IEPA.d173.s420,N1,protein kinase A
603,IEPA.d173,True,"Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons",IEPA.d173.s421,PrP(c),protein kinase C
604,IEPA.d173,False,"Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons",IEPA.d173.s421,PrP(c),protein kinase A
605,IEPA.d173,False,"Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons",IEPA.d173.s421,protein kinase C,protein kinase A
606,IEPA.d174,True,"Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration",IEPA.d174.s422,flavonols,cholesterol
607,IEPA.d174,True,"Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration",IEPA.d174.s422,flavones,cholesterol
608,IEPA.d174,True,"Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration",IEPA.d174.s422,isoflavones,cholesterol
609,IEPA.d174,False,"Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration",IEPA.d174.s422,flavonols,flavones
610,IEPA.d174,False,"Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration",IEPA.d174.s422,flavonols,isoflavones
611,IEPA.d174,False,"Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration",IEPA.d174.s422,flavones,isoflavones
612,IEPA.d174,True,"The total intake of flavonoids was inversely correlated with the plasma total cholesterol concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL cholesterol concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake",IEPA.d174.s423,flavonoids,cholesterol
613,IEPA.d174,True,"The total intake of flavonoids was inversely correlated with the plasma total cholesterol concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL cholesterol concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake",IEPA.d174.s423,flavonoids,cholesterol
614,IEPA.d174,False,"The total intake of flavonoids was inversely correlated with the plasma total cholesterol concentration (TC) (r = -0.236, P: < 0.05) and plasma LDL cholesterol concentration (LDL-C) (r = -0.220, P: < 0.05), after the adjustment for age, body mass index and total energy intake",IEPA.d174.s423,cholesterol,cholesterol
615,IEPA.d175,False,"Although the above data are consistent with a direct ability of leptin to promote TRH biosynthesis through actions on TRH neurons, addition of a-MSH produced a 3.5 fold increase in TRH biosynthesis and release, whereas NPY treatment suppressed ~3 fold proTRH biosynthesis",IEPA.d175.s424,leptin,NPY
616,IEPA.d176,True,"For example, leptin suppresses neuropeptide Y (NPY) expression in the arcuate nucleus",IEPA.d176.s425,leptin,neuropeptide Y
617,IEPA.d177,True,"As expected, in fusion of NPY alone (18 microg/day) augmented food intake (191.6% over the initial control, P < 0.05) and produced a 25.1% weight gain in conjunction with a 10-fold increase in serum leptin concentrations at the end of the 7-day period",IEPA.d177.s426,NPY,leptin
618,IEPA.d177,True,"Interestingly, coinfusion of this regimen of NPY with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum leptin concentrations and hypothalamic NPY gene expression",IEPA.d177.s427,NPY,leptin
619,IEPA.d177,False,"Interestingly, coinfusion of this regimen of NPY with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum leptin concentrations and hypothalamic NPY gene expression",IEPA.d177.s427,NPY,NPY
620,IEPA.d177,False,"Interestingly, coinfusion of this regimen of NPY with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum leptin concentrations and hypothalamic NPY gene expression",IEPA.d177.s427,leptin,NPY
621,IEPA.d177,False,"These results demonstrate that chronic central infusion to produce a persistent elevation of the cytokine at pathophysiological levels (a situation that may normally manifest during infection, injury and inflammation) produced severe anorexia and weight loss in conjunction with reduction in both serum leptin concentrations and hypothalamic NPY gene expression",IEPA.d177.s428,leptin,NPY
622,IEPA.d178,True,A caveolin-1-dependent coupling of PrPc to the tyrosine kinase Fyn was observed,IEPA.d178.s429,PrPc,tyrosine kinase Fyn
623,IEPA.d179,True,"Recently several significant advances have been made in this area, including the identification of the appetite regulating hormone, leptin, and a detailed understanding of its targets in the central nervous system (CNS), such as neuropeptide Y (NPY) and the melanocortin-4 receptor",IEPA.d179.s430,leptin,neuropeptide Y
624,IEPA.d180,True,A loop system exists between hypothalamic neuropeptide Y (NPY) and peripheral adipose tissue leptin to maintain normal body homeostasis,IEPA.d180.s431,neuropeptide Y,leptin
625,IEPA.d180,True,"When infused i.c.v. to normal rats to mimic its central effects, leptin decreases NPY levels, thus food intake and body weight",IEPA.d180.s432,leptin,NPY
626,IEPA.d180,False,Circadian fluctuations of NPY and leptin levels maintain normal body homeostasis,IEPA.d180.s433,NPY,leptin
627,IEPA.d180,True,"Leptin increases the expression of uncoupling proteins (UCP-1, -2, -3) and thus energy dissipation",IEPA.d180.s434,Leptin,uncoupling proteins
628,IEPA.d181,True,"Activity and expression of the three UCP's are stimulated by several neuromediators and hormones such as noradrenaline, tri-iodothyronine and leptin",IEPA.d181.s435,UCP,leptin
629,IEPA.d182,True,"The effect of leptin in adult rats appears to be exerted at hypothalamic level by regulating growth hormone releasing hormone (GHRH), somatostatin and neuropeptide Y (NPY)-producing neurones",IEPA.d182.s436,leptin,neuropeptide Y
630,IEPA.d183,False,"Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus",IEPA.d183.s437,neuropeptide Y,leptin
631,IEPA.d183,False,"Experimental studies provided evidences that leptin, cholecystokinin (CCK), galanin (GAL), neuropeptide Y (NPY) and insulin are involved in feeding behaviour",IEPA.d183.s438,leptin,neuropeptide Y
632,IEPA.d183,False,"Plasma concentrations of FSH, leptin, CCK, GAL, NPY and insulin were determined using commercial RIA kits",IEPA.d183.s439,leptin,NPY
633,IEPA.d183,False,"Our results, ie higher mean plasma NPY levels in postmenopausal diabetic women and positive correlation of CCK with leptin and insulin, may suggest the role of these neuropeptides in metabolic disorders leading to type 2 diabetes mellitus",IEPA.d183.s440,NPY,leptin
634,IEPA.d184,False,These results suggest that T3 may increase UCP family expression independent of leptin action,IEPA.d184.s441,UCP,leptin
635,IEPA.d185,False,"The ARC NPY neurones are stimulated by starvation, probably mediated by falls in circulating leptin and insulin (which both inhibit these neurones), and contribute to the increased hunger in this and other conditions of energy deficit",IEPA.d185.s442,NPY,leptin
636,IEPA.d185,False,"ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor",IEPA.d185.s443,NPY,leptin
637,IEPA.d185,False,"ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor",IEPA.d185.s443,NPY,leptin
638,IEPA.d185,False,"ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor",IEPA.d185.s443,leptin,leptin
639,IEPA.d186,False,"Insulin secretion, inositol phosphate levels, and phospholipase C isozymes in rodent pancreatic islets",IEPA.d186.s444,Insulin,phospholipase C
640,IEPA.d186,True,These findings are consistent with the concept that the underexpression of the nutrient-activated PLC isozyme may account for the minimal inositol phosphate (IP) and second-phase insulin secretory response from mouse islets,IEPA.d186.s445,PLC,insulin
641,IEPA.d187,True,Gibbestatin B inhibits the GA-induced expression of alpha-amylase expression in cereal seeds [In Process Citation],IEPA.d187.s446,GA,alpha-amylase
642,IEPA.d187,True,The expression of alpha-amylase in aleurone layers of barley is known to be induced by gibberellin A3 (GA).,IEPA.d187.s447,alpha-amylase,gibberellin A3
643,IEPA.d187,True,"In the present study, gibbestatin B (GNB) was isolated from Streptomyces sp. C-39 as an inhibitor of the GA-induced expression of alpha-amylase in barley and rice, with IC50 values of 125 and 70 microM, respectively.",IEPA.d187.s448,GA,alpha-amylase
644,IEPA.d187,True,GNB suppressed accumulation of GA-induced barley high-pI type B and rice RAmylA alpha-amylase transcripts.,IEPA.d187.s449,GA,alpha-amylase
645,IEPA.d187,True,"These analyses indicate that GNB inhibits the GA-induced expression of alpha-amylase by regulating one of the steps involved in ABA signaling, but not by acting as a weak ABA analog.",IEPA.d187.s450,GA,alpha-amylase
646,IEPA.d188,True,"We also determined whether well known hypothalamic neuropeptide targets, e.g. neuropeptide Y (NPY), proopiomelanocortin (POMC), agouti-related peptide (AGRP) and cocaine and amphetamine-regulated transcript (CART) were regulated in a pattern consistent with their presumed roles as mediators of leptin action",IEPA.d188.s451,neuropeptide Y,leptin
647,IEPA.d188,True,"In contrast, leptin decreased body weight and adiposity, increased CART and suppressed NPY and AGRP mRNA expression in adult mice",IEPA.d188.s452,leptin,NPY
648,IEPA.d190,True,Leptin effects on pulsatile gonadotropin releasing hormone secretion from the adult rat hypothalamus and interaction with cocaine and amphetamine regulated transcript peptide and neuropeptide Y [In Process Citation],IEPA.d190.s454,Leptin,neuropeptide Y
649,IEPA.d190,True,Leptin may act as a negative feedback signal to the hypothalamic control of appetite through suppression of neuropeptide Y (NPY) secretion and stimulation of cocaine and amphetamine regulated transcript (CART).,IEPA.d190.s455,Leptin,neuropeptide Y
650,IEPA.d190,False,"We aimed at studying the effects of leptin, CART and NPY on the hypothalamic control of the pituitary-gonadal system.",IEPA.d190.s456,leptin,NPY
651,IEPA.d190,False,The increase in GnRH pulse amplitude caused by leptin was totally prevented by coincubation with an anti-CART antiserum whereas it was not affected by coincubation with the NPY Y5-receptor antagonist (10(-7) M).,IEPA.d190.s457,leptin,NPY
652,IEPA.d190,False,"In conclusion, leptin and NPY show separate permissive effects on GnRH secretion in the adult rat hypothalamus.",IEPA.d190.s458,leptin,NPY
653,IEPA.d191,True,"Similarly, central leptin treatment also had a greater effect in suppressing hypothalamic NPY mRNA expression in young (-23+/-4%) than in old (-8+/-4%) rats compared with their age-matched pair-fed treated rats",IEPA.d191.s459,leptin,NPY
654,IEPA.d192,True,"Compared with the wild type, GA induction of alpha-amylase activity in aleurone cells of d1 was greatly reduced",IEPA.d192.s460,GA,alpha-amylase
655,IEPA.d192,True,"Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase",IEPA.d192.s461,GA,alpha-amylase
656,IEPA.d192,False,"Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase",IEPA.d192.s461,GA,GA
657,IEPA.d192,False,"Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase",IEPA.d192.s461,alpha-amylase,GA
658,IEPA.d192,True,"However, in the presence of high GA concentrations, alpha-amylase induction occurred even in d1",IEPA.d192.s462,GA,alpha-amylase
659,IEPA.d192,True,"All these results suggest that d1 affects a part of the GA-signaling pathway, namely the induction of alpha-amylase in the aleurone layer and internode elongation",IEPA.d192.s463,GA,alpha-amylase
660,IEPA.d193,False,"Finally, recent evidences suggest that melanocortins could be involved in mediating the effects of leptin, and in controlling the expression of neuropeptide Y (NPY)",IEPA.d193.s464,leptin,neuropeptide Y
661,IEPA.d194,True,Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase Cgamma and protein kinase Calpha signalling cascade.,IEPA.d194.s465,Insulin,phospholipase Cgamma
662,IEPA.d194,False,"Co-expression of PLD1 with phospholipase C (PLC)gamma has the same effect, while co-expression of PLD2 with PLCgamma allows PLD2 activity to be stimulated in an insulin-dependent manner.",IEPA.d194.s466,phospholipase C (PLC)gamma,PLCgamma
663,IEPA.d194,False,"Co-expression of PLD1 with phospholipase C (PLC)gamma has the same effect, while co-expression of PLD2 with PLCgamma allows PLD2 activity to be stimulated in an insulin-dependent manner.",IEPA.d194.s466,phospholipase C (PLC)gamma,insulin
664,IEPA.d194,False,"Co-expression of PLD1 with phospholipase C (PLC)gamma has the same effect, while co-expression of PLD2 with PLCgamma allows PLD2 activity to be stimulated in an insulin-dependent manner.",IEPA.d194.s466,PLCgamma,insulin
665,IEPA.d194,False,"The PKC-specific inhibitors bisindolylmaleimide and Go 6976 abolish insulin-induced PLD2 activation in HEK-293 cells co-expressing the insulin receptor, PLCgamma and PLD2, confirming that not only PLD1, but PLD2 as well, is regulated in a PKC-dependent manner.",IEPA.d194.s467,insulin,PLCgamma
666,IEPA.d194,True,"In summary, we demonstrate that insulin treatment results in activation of both PLD1 and PLD2 in appropriate cell types when the appropriate upstream intermediate signalling components, i.e. PKCalpha and PLCgamma, are expressed at sufficient levels.",IEPA.d194.s468,insulin,PLCgamma
667,IEPA.d196,False,Both receive information about the nutritional status and the level of energy storage through insulin and leptin signaling mediated by specific receptors located on POMC and NPY neurons present predominantly in the arcuate nucleus (ARC).,IEPA.d196.s476,leptin,NPY
668,IEPA.d196,False,"When leptin signaling is defective, through a defect in either the receptor (Zucker fa/fa rat, cp/cp rat, and db/db mouse) or in the peptide itself (ob/ob mouse), the NPY system is upregulated as shown by mRNA overexpression and increased peptide release, whereas the content and/or release of some inhibitory peptides (neurotensin, cholecystokinin) are diminished.",IEPA.d196.s477,leptin,NPY
669,IEPA.d197,True,Bovine prion protein as a modulator of protein kinase CK2,IEPA.d197.s478,Bovine prion protein,protein kinase CK2
670,IEPA.d197,True,"On the basis of far-Western blot and plasmon resonance (BIAcore) experiments, we show here that recombinant bovine prion protein (bPrP) (25-242) strongly interacts with the catalytic alpha/alpha' subunits of protein kinase CK2 (also termed 'casein kinase 2')",IEPA.d197.s479,bovine prion protein,protein kinase CK2
671,IEPA.d197,False,We also show that bPrP counteracts the inhibition of calmodulin phosphorylation promoted by the regulatory beta subunits of CK2,IEPA.d197.s480,bPrP,CK2
672,IEPA.d197,True,A truncated form of bPrP encompassing the C-terminal domain (residues 105-242) interacts with CK2 but does not affect its catalytic activity,IEPA.d197.s481,bPrP,CK2
673,IEPA.d197,True,"These results disclose the potential of the PrP to modulate the activity of CK2, a pleiotropic protein kinase that is particularly abundant in the brain",IEPA.d197.s482,PrP,CK2
674,IEPA.d197,False,"These results disclose the potential of the PrP to modulate the activity of CK2, a pleiotropic protein kinase that is particularly abundant in the brain",IEPA.d197.s482,PrP,protein kinase
675,IEPA.d197,False,"These results disclose the potential of the PrP to modulate the activity of CK2, a pleiotropic protein kinase that is particularly abundant in the brain",IEPA.d197.s482,CK2,protein kinase
676,IEPA.d198,True,"Arcuate nucleus NPY mRNA increased in rats given protein-free diet, correlating with leptin rather than decreased feeding",IEPA.d198.s483,NPY,leptin
677,IEPA.d199,True,The induction of alpha-amylase triggered by gibberellic acid in barley embryos is repressed by sugars,IEPA.d199.s484,alpha-amylase,gibberellic acid
678,IEPA.d199,False,"Our results indicate that glucose represses gibberellin signalling late along this hormone transduction pathway, downstream of transcription of the gibberellin-modulated transcriptional activator (GAMYB) needed for alpha-amylase induction",IEPA.d199.s485,gibberellin,gibberellin
679,IEPA.d199,False,"Our results indicate that glucose represses gibberellin signalling late along this hormone transduction pathway, downstream of transcription of the gibberellin-modulated transcriptional activator (GAMYB) needed for alpha-amylase induction",IEPA.d199.s485,gibberellin,alpha-amylase
680,IEPA.d199,False,"Our results indicate that glucose represses gibberellin signalling late along this hormone transduction pathway, downstream of transcription of the gibberellin-modulated transcriptional activator (GAMYB) needed for alpha-amylase induction",IEPA.d199.s485,gibberellin,alpha-amylase
